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Abstract 
 
 
This multidisciplinary project begins with one overarching aim: to elucidate the role of the 
rigidity of the lipid tail on the phase transitions of lipidic mesophases. Previous studies have 
demonstrated that the position and the number of cis double bonds in monoacylglycerols 
determine the chain splay of the molecule, establishing how this parameter was essential in 
influencing the phase behavior. Following on from this, novel lipids which are inspired by 
naturally occuring cyclopropanated lipids have been synthesized, and their phase behavior 
elucidated. The chain rigidity has been systematically varied by locking the cis configuration 
of the double bond on the alkyl chain in a confined geometry. To understand the relationship 
between chain rigidity and phase behavior a library of new lipids has been synthesized replacing 
the cis double bond by a geometrically confined cyclopropyl ring. The replacement of the 
double bond with a chemically analogous cyclopropyl group was designed in order to maintain 
a similar chain splay and CPP parameter. The insertion of an additional carbon into the lipidic 
chain doesn’t significantly change the length or the curvature of the chain but varies 
substantially the packing frustration and the lateral stress of the lipid. 
The phase behavior of these novel lipids with identical head group and different alkyl chains 
has been investigated with utmost care. Small angle X-ray scattering (SAXS) measurements at 
different hydration level and at different temperatures have been used to study the thermal 
behavior of these lipid and the effect of this novel motif on the lipidic packing, with particular 
attention to low temperature effects. 
Since cyclopropanated lipids are present in several dairy products, and since lipidic 
nanoparticles have been proved to be excellent drug delivery systems, digestion studies of 
cubosomes and hexosomes formed by the novel synthesized cyclopropanated lipids have been 
performed. Time resolved synchrotron SAXS has been used to monitor the phase changes 
during the enzymatic reaction.  
In order to test the utility of the cyclopropanated lipidic systems for membrane protein 
crystallization the novel lipidic cubic phase (LCP) matrices have been employed in 
crystallization studies with the membrane protein model system bacteriorhodopsin (bR).  
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Finally, the successful crystallization attempts for membrane protein structural studies of the 
chloride channels EcClC and Rm1ClC, as well as the lipopolysaccharide transporter LptD-LptE 
show the broad applicability of the LCP crystallization method and the utility of tuning 
crystallization conditions, including a screening of different lipids, to optimize crystal growt. 
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Zusammenfassung 
 
 
Das übergeordnetes Ziel dieses interdisziplinären Projektes, ist die Rolle der Rigidität der Lipidkette auf 
die Phasenübergängen der lipidischen Mesophasen zu untersuchen. Frühere Studien haben gezeigt, dass 
die Position und die Anzahl der cis-Doppelbindungen in Monoacylglycerolen deren Spreizung wesentlich 
beeinflussen und zudem wirken sich diese Parameter auf das Phasenverhalten aus. Ausgehend von diesen 
Erkenntnissen wurden neue, von den natürlich vorkommenden cyclopropylierten Lipiden inspirierte 
Moleküle synthetisiert und deren Phasenverhalten untersucht. Die Rigidität der Lipidkette wurde 
systematisch variiert, indem cis-Doppelbindungen in verschiedenen Molekülen durch 
Cyclopropylgruppen ersetzt wurden und die Position und Anzahl der Cyclopropylringe in der Alkylkette 
verändert wurde. Diese Substitution wurde gewählt, weil dabei eine ähnliche Geometrie eingenommen 
und der CPP (Kritischer Packungsparameter) Parameter nicht signifikant verändert wird. Das damit 
zusätzlich eingefügte Kohlenstoffatom in die Lipidkette verändert die Länge beziehungsweise die 
Krümmung der Kette in geringem Ausmass, hat jedoch einen Einfluss auf die Packungsfrustration und 
den lateralen Stress des Lipids. 
Das Phasenverhalten dieser neuartigen Lipide mit identischen Kopfgruppen und unterschiedlichen 
Alkylketten wurde akribisch untersucht. Kleinwinkel-Röntgenstreuungs-Messungen (SAXS) auf 
verschieden Hydratisierungsstufen und bei verschiedenen Temperaturen wurden verwendet um das 
thermale Verhalten von diesen Lipiden zu untersuchen. Zudem wurde der Effekt der Cyclopropylgruppe 
auf die lipidische Packung, mit Berücksichtigung der Tieftemperatureffekten erforscht. 
Da cyclopropylierte Lipide in Milchprodukten vorkommen und lipidische Nanopartikel exzellente Drug 
Delivery Systeme sind, wurde die Enzymkinetik des Abbaus dieser neuen cyclopropylierten Lipide in 
Cubosomen und Hexosomen untersucht. Mittels zeitaufgelösten Synchrotron SAXS Messungen wurden 
die Phasenübergänge während der enzymatischen Reaktion über die Zeit verfolgt. 
Um die Anwendung der cyclopropylierten Lipidsysteme in der Proteinkristallisation in neuartigen Lipiden 
zu testen, wurden kubischen Phasen (LCP) in Kristallisationsstudien mit dem Membranprotein-
Modellsystem Bakteriorhodopsin (bR) verwendet. Die erfolgreichen Kristallisationen für die 
Membranprotein-Struktur-Untersuchung der Chloridkanäle EcClC und Rm1ClC, sowie des 
Lipopolysaccharid Transporters, beweisen die breite Anwendbarkeit dieser LCP-Kristallisationsmethode. 
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Zudem wurde die Nützlichkeit der möglichen Feinabstimmung der Kristallisationsbedingungen inklusive 
des Screenings von verschiedenen Lipiden um das Kristallwachstum zu optimieren, gezeigt. 
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Chapter 1 
 
Introduction  
 
 
1.1 Lipidic mesophases 
Lyotropic liquid crystals are viscous materials that have intermediate characteristics between 
liquid and solid crystalline materials. They are formed by the spontaneous assembly of 
amphiphilic molecules in presence of a solvent. In these mesophases, the molecules are ‘liquid-
like’ as they are mobile, but can only diffuse within an ordered geometry characteristic of 
crystalline solid. The dual molecular nature of amphiphiles, composed of a hydrophobic tail 
and a hydrophilic head group, governs the assembly process of these molecules in polar solvents 
such as water, resulting in formation of various materials with several geometries and different 
physical characteristics. Generally, lipids have the ability to form supramolecular structures in 
aqueous systems, assembling in different phases according to pressure, temperature, molecular 
shape and composition. This phenomenon is known as lipid polymorphism (1). Typical lipidic 
liquid crystalline phases are lamellar (Lα), micellar (L), hexagonal (H) and cubic (Q). The Lα 
phase consists of stacked planar lipidic bilayers separated by water. In micelles, lipid molecules 
are arranged in a spherical geometry that encompasses water.  
Of particular interest to this work are the 3D and 2D mesophases which will be discussed in 
more detail in section 1.4 and 1.5. Briefly, cubic phases comprise of a single curved lipidic 
bilayer arranged spacially in an infinite periodic minimal surface that delineates two identical, 
but not interconnected aqueous channels (2). The type of surface symmetry can vary, resulting 
in the formation of different cubic phases, namely with gyroid (Ia3d), double diamond (Pn3m), 
or primitive symmetry (Im3m). In the 2D hexagonal phase, the lipidic molecules aggregate in 
cylinders that are packed in a hexagonal lattice. These curved systems can be divided into two 
main groups: oil-in-water or normal phases, in which the lipidic tails aggregate due to 
hydrophobic effect so as to avoid contact with water, while the polar head groups protrude to 
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the external part of the aggregate and are in contact with water (HI, L1); and water-in-oil or 
inverse structures in which the water is confined in pores constituted by the polar head groups, 
while the lipidic tails point out of the aggregate (HII, L2) (Figure 1).  
 
 
Figure 1. Schematic illustration of lipid polymorphism in water. The phase sequence is expressed in 
accordance with the critical packing parameter, CPP = ν/al, where ν is the volume of the lipidic 
chain, a is the cross-sectional area of the head group, and l is the length of the molecule. Reproduced 
with permission from (3) 
 
In this context, cis-monoacylglycerols are a class of lipids known for their unique lyotropic 
liquid crystalline polymorphism, and for their ability to undergo phase transition to non-
lamellar phases. They have been intensely studied due to their ability to form lipidic 
bicontinuous cubic phases (LCPs) in particular (4), the latter being used in numerous 
biomedical applications.  
This distinct family of lipids is naturally synthesized by the enzymatic hydrolysis of the more 
abundant triglycerides, thereby yielding amphiphiles that consist of one molecule of glycerol 
connected to a cis unsaturated fatty acid via an ester bond (Figure 2). 
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Figure 2. Four cis-monoacylglycerols of interest in this study. They exhibit different hydrophobic chain 
lengths, different number of cis double bonds and different position of the unstauration: monoolein 
(MO), monopalmitolein (MP), monovaccein (MV), and monolinolein (ML). 
 
The physicochemical properties of the hydrophilic and hydrophobic moieties of amphiphiles 
determine their phase behavior upon hydration. Specifically, the capability of the head group 
to form H-bonds, the size and hydrophilicity of the lipid, together with the presence of an 
isoprenoid or unsaturated hydrocarbon chain are considered fundamental factors to allow a 
diversified polymorphism and for the formation of LCPs. Variation of the head group of these 
lipids, through the introduction of different moieties such as sugars or pentaerythritol in order 
to preserve the ability to form strong H-bonds, have been attempted and have led to the synthesis 
of novel synthetic lipids with alternative chemical properties but similar phase behavior (5-8). 
While the possibility of altering the head group, albeit with certain limitations and problems, 
has been explored in the past, the presence of a cis double bond or an isoprenoid structure in 
the lipidic chain seems to be a necessity for the formation of the different cubic phases (9). The 
branched chain of the isoprenoid moiety, or the presence of one or more cis double bonds, 
provide in most cases the correct curvature and rotational and translational motions in order to 
obtain inverse structures in general, and LCPs in particular (10). 
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1.2 Lipid molecular shape and properties of the ensuing mesophase 
In order to be able to control and tune the phase behavior in general, and the phase transitions 
in particular, as well as the fundamental characteristics of each geometrical phase, chemical 
and physical aspects of the lipidic building blocks have to be taken into consideration.  
The driving force for formation of the aggregates is the hydrophobic effect: In order to avoid 
water-oil interactions, surfactants associate forcing the lipidic chains to aggregate so as to 
exclude contact with water (11). In order to minimize the dissolution energy of the system, the 
hydrophobic effect avoids decreasing of entropy connected with the solvation of lipidic 
moieties by water. The bilayer formation and its conformation is the result of the sum of various 
complex attractive and repulsive interactions. For the inverse curved bilayer, like those found 
in LCPs, these interactions are even more complicated because the tendency of the surface to 
attain its curvature is controlled by the repulsive lateral pressure in the chain region, the 
interfacial pressure and the lateral stress around the head group (H-H bond, steric and 
hydrational interactions) (12).  
 
One of the first parameters developed to explain such lipid behavior is the tendency of a 
monolayer to bend into a particular curvature as a function of the molecular shape of the lipidic 
building block. The critical packing parameter (CPP, Equation 1) correlates the ratio between 
the splay of the hydrocarbon chain (volume and length) and the effective head group area, with 
the capacity of lipids to form inverse structures (Figure 1) (13).  
 
𝐶𝑃𝑃 = 𝜈/𝑎𝑙                       (1) 
Where ν is the volume of the incompressible hydrocarbon chain, a is the cross-sectional area of 
the head group, and l is the maximum length that the chain can assume. This model, which is 
useful as an indication for amphiphilic self assembly, does not explain the existence of 
intermediate bicontinuous cubic phases (9). 
 
The free energy of the system is an extremely important factor in the formation of inverse 
phases. It is determined by the competition between the tendency of the membrane to achive a 
curvature and the packing frustration of the hydrocarbon chains (Equation 2) (14, 15). 
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𝑔𝑡𝑜𝑡 = 𝑔𝑐 + 𝑔𝑝                         (2) 
 
In this model, the free energy of the system (gtot) is expressed as the sum of two contributions: 
gc = the free energy associated with the curvature of the system, which can be calculated for 
each lipid in each geometry starting from Equation 1 and gp = free energy associated with the 
packing frustration.  
 
For a curved geometry, the packing frustration is generated by the necessity of the lipidic chains 
to assume different lengths to fill up the available space. For the molecular shape and the splay 
of the lipidic chain to force the system to become curved, the free energy of the system would 
be minimized when the mean curvature of the bilayer is constant and the lipidic length is 
identical for each molecule. Fulfilling these two requirements is not possible for curved 
systems, and therefore the free energy of curved phases is always frustrated. As a result, in 
order to relieve the frustration, a change in global curvature or a phase transition will occur in 
response to lateral stresses imposed on the surfactant monolayer when environmental 
parameters (e.g. temperature, pressure, solvation, and additives) change. This balance of forces 
makes these systems able to switch phases and change curvature under the influences of 
external parameters. 
Despite the availability of these models, due to the complexity and the number of interactions 
and energies involved in the formation of each packing geometry, rules that can precisely 
predict a priori the phase behavior and transition temperatures and concentrations of various 
lipids based on their molecular structure alone are not available. For this reason, engineering of 
novel lipidic molecules that demonstrate lipid polymorphism, thus enabling the possibility of 
switching phases in a controlled manner is still a formidable challenge. Molecular design of 
lipidic building blocks that control the phase behavior of the ensuing matrix is a long-term goal 
that can only be achieved by starting from phase behavior studies on common lipids or on novel 
lipids with small, systematic mutations.   
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1.3 Phase behavior of the monoolein-water system  
Within the cis-monoacylglycerol family, the best characterized and most utilized lipid is 
monoolein (MO). MO is especially popular for its ability to form stable LCPs at room 
temperature and in an excess of water. MO was one of the first lipids discovered that form 
bicontinuous cubic phases upon hydration and is one of the most used lipids in drug delivery 
and membrane protein crystallization studies. 
 
MO is comprised of a single oleoyl chain linked to a glycerol head group by an ester bond 
(Figure 2). The phase behavior of hydrated MO and the structure and properties of various 
phases formed have been well established (Figure 3) (16).  
 
 
Figure 3. Comparison of monoolein-water phase diagrams studied from 1965 to 2000. a) The viscous 
isotropic phase described by Lutton in 1965 (17) corresponds to the isotropic cubic phase characterized 
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by Luzzati in 1968 (4). b) Hyde determined the geometry of the low hydration cubic phase, reporting in 
1984 a transition between a gyroid (Ia3d) and diamond (Pn3m) cubic phase (18). c) Briggs extended the 
phase studies to low temperature in 1996 (19). d) Supercooling effect with a low temperature 
thermodynamic instability of LCPs was reported by Qui in 2000 (20). Reproduced with permission from 
(16).  
 
MO polymorphism has been reported in several phase diagram studies reported in Figure 3, in 
which hydration and temperature were varied in a systematic way and phase transitions were 
determined by small angle x-ray scattering (SAXS), light microscopy or differential scanning 
calorimetry (DSC) (17-20). Upon hydration at ambient temperatures, MO shows transition from 
a lamellar crystalline phase (Lc), in which lipidic molecules are organized in a solid crystalline 
bilayer to L, a liquid crystalline phase in which the planar bilayer has higher mobility and the 
molecules can diffuse laterally. By increasing the temperature of the systems at low hydration, 
the first transition is to the isotropic fluid (FI), composed of inverse micelles of surfactant and 
water (L2). At higher water contents, the lamellar geometry undergoes a reorganization, forming 
three dimensional bicontinuous cubic phase initially with Ia3d, and subsequently with Pn3m 
geometry, the latter being stable in excess of water. By increasing the temperature of systems 
with a water content higher than 15% to 85°C, the cubic geometry collapses into a highly curved 
inverse hexagonal phase. The resulting HII phase is stable in excess of water at temperatures up 
to 100°C. The ability to switch phases by increasing hydration and, most importantly, 
temperature, makes these mesophases appealing for several applications in which order-to-
order transitions can be induced to change properties of the material (diffusion coefficient, 
interface availability etc.).  
 
1.4 Lipidic cubic phases 
Bicontinuous cubic phases are thermodynamically stable lipidic mesophases that can form in 
various defined space group geometries: the double gyroid (Ia3d) cubic phase with three-fold 
water channels, the double diamond (Pn3m) one with four-fold water channels, and the 
primitive (Im3m) cubic phase with six-fold water channels (2, 18). These geometries are 
depicted in Figure 4. These 3D architectures exhibit different symmetries, but they share the 
following features: they are constituted by a curved lipid bilayer that forms an infinite periodic 
minimal surface with zero mean curvature, which is surrounded by two identical, but non-
intersecting aqueous channels. Moreover, in the fully hydrated systems i.e. Pn3m and Im3m, 
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lipid and water molecules can diffuse within their respective molecular compartments, and 
water can diffuse between the channels and an excess reservoir (21). A discontinuous cubic 
structure, which consists of reverse micelles packed in cubic crystalline domains (Fd3m) has 
also been intensely studied (8).  
 
         
Figure 4. Representation of the topology of the three bicontinuous cubic phases with particular attention 
to the aqueous channel geometry. The water channels are depicted in blue and green, while the lipidic 
bilayer is colored in gold-yellow. A) Ia3d double gyroid cubic phase, B) Pn3m double diamond cubic 
phase, and C) Im3m primitive cubic phase. 
 
Geometrical considerations can be used in order to calculate the aqueous channel radius. For 
the inverse bicontinuous cubic phases, the water-lipid interface is assumed to be parallel to the 
underlying minimal surface (TPMS) (22). By knowing from SAXS measurements the geometry 
and the lattice parameter a, and knowing the lipid volume fraction of the sample ϕ, the length 
of the lipid tail, l, can be calculated by solving the following cubic equation (23): 
 
Φ = 2𝐴0 (
𝐿𝑙𝑖𝑝
𝑎
) +
4
3
𝜋𝜒 (
𝐿𝑙𝑖𝑝
𝑎
)
3
                     (3) 
 
where 𝐴0 is the area of the surface in the unit cell in which the lattice parameter is equal to 
unity, and 𝜒 is the Euler-Poincare characteristic. Depending on the specific cubic phase they 
have the following values: 𝐴0 = 3.091 and 𝜒 = −8 for Ia3d; 𝐴0 = 1.919 and 𝜒 = −2 for 
Pn3m; and 𝐴0 = 2.345 and 𝜒 = −4 for Im3m. For the radius of the aqueous channels, r the 
following equations are valid for the Ia3d, Pn3m and Im3m phases, respectively (19): 
A B C 
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𝑟 = 0.248𝑎 − 𝐿𝑙𝑖𝑝                       (4a) 
𝑟 = 0.391𝑎 − 𝐿𝑙𝑖𝑝                       (4b) 
𝑟 = 0.3055𝑎 − 𝐿𝑙𝑖𝑝                     (4c) 
 
1.5 Hexagonal phase 
In the hexagonal symmetry, lipidic monolayers form cylinders that are organized in a hexagonal 
packing arrangement. Monoacylglycerols usually present an inverse hexagonal phase, with the 
water confined into cylinders formed by the polar headgroups of lipids, while the hydrophobic 
tails protrude into the external interface of the aggregates (24). For hydrated monoacylglycerols 
the HII phase appears at high temperatures (70-100 °C), as is the case for MO (20). These 
systems are highly curved and the lipidic chains are densely packed and stressed. To overcome 
the free energy related to the lipidic chain stress, the curvature required from the lipid molecular 
shape needs to be optimized. For these systems, the lipidic wedge shape increases at high 
temperature when H-bonds between the lipid’s polar head groups and water molecules are 
broken. This loss of hydration sphere results in decrease of the head group cross sectional area.  
 
       
Figure 5. Schematic representation of A) normal, and B) inverse hexagonal phases formed from 
aggregation of lipid molecules in the presence of water. Polar head groups are shown in red, apolar 
chains are shown in grey. The highly curved lipidic monolayers constitute cylinders that are organized 
in a hexagonal packing arrangement. In the normal phase, the water is confined to the external interface 
of the cylindrical aggregates, while in the inverse phase the cylinders constitute the aqueous channels. 
Reproduced with permission from (25). 
A B 
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Calculation of the aqueous channel radius of the HII phase must take into account both the 
cylindrical geometry and the packing frustration of the hydrophobic chains in the interstitial 
spaces. Therefore starting from the lattice parameter a, and the lipid volume fraction ϕ, the 
radius r, of the HII phase can be calculated using the following equation (26):  
 
𝑟 = 𝑎(1 − 𝜙)1 2⁄ (
√3
2𝜋
)
1 2⁄
                     (5) 
 
 
1.6 Properties and applications of lipidic mesophases 
The amphiphilic nature of the mesophases renders these materials ideal to encapsulate 
molecules with different polarities, sizes and chemical characteristics (27).  In the case of the 
two phases of interest, Pn3m and HII, the characteristic thermodynamic stability in excess of 
water opens up a plethora of applications, most importantly in the fields of drug delivery and 
membrane protein crystallization. The presence of aqueous nanopores with a regular structure 
and repetition enables the possibility to confine water-soluble drugs or small hydrophilic 
proteins in a controlled manner (28, 29). Most significantly, the high porosity of the system 
maximizes the interface between water and the lipidic layer, making these materials interesting 
for interfacial studies (30).  
 
1.6.1 Bulk mesophases and lipidic dispersions as drug delivery systems  
The amphiphilic properties, biocompatibility and high surface area of these lipidic mesophases 
render them ideal for application in drug delivery. The release of hydrophilic drugs incorporated 
into the mesophases has been shown to be a diffusive process regulated by the size of the 
aqueous channels and the symmetry of the mesophase: in particular, the order for release rate 
is 3D LCP >> 2D Lα>> 1D HII (31, 32). Additionally, the mesophases and actives can be 
tailored to suit each other in order to optimize the incorporation and release of selected drugs 
(33, 34). In vivo studies, have demonstrated the low toxicity of cubic phases, which maintain 
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their mesophase nanostructure and controlled release characteristics when subcutaneously 
injected (35) or orally dosed (36).  
A recent development in this field is the design of stimuli responsive drug delivery systems, 
which takes advantage of the ability to dynamically switch between the different lipidic 
nanostructures. These smart nanomaterials can be loaded with soluble drugs and an ‘on- 
demand’ release can be triggered by light, pH or temperature with the aim to significantly 
reduce or eliminate side effects (37-40).  
The ability of LCPs and the HII phase to coexist with an excess of water enables the formation 
of dispersed nanostructured particles in the presence of a stabilizer - cubosomes and hexosomes 
- with the same complex internal structures as those of the gel materials (41). Thus important 
properties such as biodegradability, amphiphilicity, geometry and lattice parameters of the bulk 
lipidic phases are correspondingly preserved in the dispersions (42). Additionally, the issues 
associated with the size and complexity of the system, as well as difficulties in handling the 
viscous, sticky bulk mesophases can be avoided by using these dispersed nanostructured 
particles.  
 
Figure 6. Cryo-TEM images of A) cubosomes and B) hexosomes. The internal structure organization 
is shown by Fast Fourier Transform (FFT) analysis. Reproduced from (43). 
 
Cubosomes have been largely studied as drug delivery systems for small hydrophilic molecules. 
However, these systems are problematic as they exhibit burst release upon dilution (44). In 
order to overcome this phenomenon, stimuli responsive lipidic particles have been developed 
(37, 38). The ideal system would be a drug delivery dispersed mesophase that can switch from  
a slow releasing geometry such as liposomes or hexosomes to a fast one like cubosomes, by 
dynamically changing environmental factors such as the pH (45), and through the application 
12 
 
 
of external stimuli such as light activation (46), or during enzymatic hydrolysis (47). These 
methods of dynamically altering phase behavior have have been conceived as the optimal 
trigger mechanism for the dynamic, controlled release of encapsulated drugs (48).  
 
1.6.2 Membrane protein crystallization  
Membrane proteins play a central role in all physiological processes in cellular systems, 
regulating vital functions such as transport, signal transduction and energy conversion. 
Knowledge of the structures of these proteins is an obligatory step towards understanding their 
function, dynamics and assembly. Moreover, membrane proteins are essential for the correct 
function of cells, and their malfunction causes several diseases such as Alzheimer’s, 
Parkinson’s, diabetes, cancer, heart failures and various other dysfunctions. It is not surprising, 
therefore, that membrane proteins constitute around 60% of the targets of approved drugs and 
the elucidation of their three-dimensional structure is fundamental for drug design (49). The 
difficulties in studying membrane proteins are mainly due to their large hydrophobic surfaces, 
flexibility and lack of stability once they are removed from their native membrane environment 
(50). These problems make it extremely challenging to handle membrane proteins, with 
difficulties related to their expression, purification, stabilization and crystallization. In 
particular, structural analysis by X-ray crystallography requires well diffracting crystals that are 
obtained by a slow and organized nucleation and crystal growth. In order to solubilize 
membrane proteins and avoid a fast precipitation they are purified in detergent solutions in 
which micelles act as a “membrane like” hydrophobic environment.  
The use of LCPs as an alternative bilayer matrix for membrane protein crystallization was 
introduced in 1996 (51) and since then, bulk LCPs have been shown to be an ideal matrix for 
the entrapment and crystallization of membrane proteins (51-53). The presence of a bilayer 
(LCP) or a “bilayer-like” (HII) lipidic environment provides matrices which act as excellent 
mimics of cellular membranes and give the possibility to embed, reconstitute and crystallize 
membrane proteins, and to incorporate other hydrophobic molecules (27, 51, 54). Their capacity 
to mimic the cell membrane in their characteristic lipophilicity, curvature, thickness and lateral 
pressure makes these materials the perfect candidate for membrane protein studies.  
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Figure 7. Purple hexagonal bacteriorhodopsin (bR) crystals grown in LCPs.  
 
Thus introduction of LCPs as tools into molecular membrane biology has revolutionized the 
field, enabling the crystallization of membrane proteins previously unseen (53). Over the last 
two decades, the capacity to produce well diffracting crystals from LCPs has resulted in an 
exponential increase of unique structures of membrane proteins (53). The families of membrane 
proteins that have been crystalized in this way range from microbial rhodopsins (Figure 7) to 
outer membrane proteins and transporters (53). Most importantly, LCP crystallization has led 
to the elucidation of high-resolution structures of numerous G protein-coupled receptors 
(GPCRs), (52, 55-57) essential for the understanding of cellular signal transduction pathways. 
Recent developments of LCP injectors for serial femtosecond crystallography at X-ray free 
electron lasers (XFELs) has made it possible to determine high resolution membrane protein 
structures of microcrystals grown in LCPs, overcoming one of the few disadvantages of LCP 
crystallization: while LCP crystals are usually very well ordered, they are generally smaller 
than protein crystals obtained using vapor diffusion techniques (58-60). Advances in the field 
have resulted in impressive progress in a very short period of time. The last successful project 
that would have been the dream of any membrane biologist only two decades ago is the 
recording of a three-dimensional atomic movie of the light induced structural changes in the 
proton pump bacteriorhodopsin embedded in LCP using XFEL serial femtosecond 
crystallography (61).  
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In addition to crystallization, the functional solubilization and reconstitution of membrane 
proteins has also been achieved, demonstrating the capacity of both cubic and hexagonal 
matrices to host active membrane proteins (Figure 8) (54, 62-64). 
 
Figure 8. Schematic representation of the functional reconstitution of A) chloride channel ec-1 (EcClC) 
in Pn3m cubic phase; B) outer membrane protein F (ompF) in HII phase. Figures reproduced with 
permission from (54, 64). 
 
As can be seen, these multicompartmentalized nanomaterials can be utilized in important 
biomedical applications. Understanding the fundamental forces that govern the self-assembly 
of the lipid molecules into the different geometries is essential to design these systems for their 
specific applications. In order to achieve this, amphiphiles that can form lipidic mesophases 
need to be understood on a fundamental level in order to control and manipulate transitions 
between the different mesophases.  
 
1.7 Aim of the thesis 
Development of alternative lipids that can form lipidic mesophases with interesting properties 
is called for, given the the increasing number and scope of applications of these systems in drug 
delivery, as bio-compatible sensors and for membrane protein studies. The design of novel 
molecules that show complex polymorphism is hard to achieve, and thus systematic studies to 
explore the effect of small structural changes of the lipidic building blocks on the lipidic phase 
behavior are essential to understand the rules that govern phase formation. Starting from the 
consideration that replacing cis double bonds by cyclopropanated systems retains most of the 
chemical and geometrical properties, we hypothesized that cyclopropanated lipids will maintain 
A B 
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the complex phase behavior of the parent monoacylglycerides, and that the resulting new 
materials can be usefully utilized for several applications. 
Thus the aims of this project are to: 
 
 Design and synthesize novel lipids which are inspired by naturally occuring 
cyclopropanated lipids; 
 Study of the phase behavior of these novel lipids by SAXS measurements at different 
hydration levels and at different temperatures, with particular attention to low 
temperature effects; 
 Elucidate the role of the lipid tail’s rigidity on the phase behavior of lipidic mesophases 
by comparison of the molecular structure and the phase transition bundaries of the novel 
lipids with those of commonly used monoacylglycerols; 
 Test the utility of the synthesized cyclopropanated lipids as building blocks of drug 
delivery systems forming lipidic suspensions, and monitor their enzymatic digestion by 
time resolved synchrotron SAXS. 
 Establish the applicability and the advantages of varying lipids for in cubo membrane 
protein crystallization. 
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Chapter 2 
 
Synthesis of novel lipids for lipidic mesophase studies. 
 
 
Cyclopropanated lipids 
Several lipidic systems show a complex phase behavior, known as lipidic polymorphism in 
presence of water. By varying the level of hydration, they are able to generate aggregates with 
different curvatures, geometries and physical proprieties (1). Due to the liquid crystalline nature 
of these phases they are known as mesophases: both water and lipid are free to diffuse 
maintaining a semi-ordered lattice. Within lipidic mesophases, lipidic cubic phases (LCPs) 
fulfill a special role: LCPs are bicontinuous mesophases in which a curved  lipid bilayer is 
interdigitated with two identical and not connected aqueous channels to form a minimal surface 
geometry (2). LCPs are unique nanostructured matrices that have been lauded for their 
advantageous characteristics such as biocompatibility, amphiphilicity and their “membrane-
like” nature. These features have been utilized in several disciplines of science and technology 
from membrane biology (3-7), drug delivery (8-10), food emulsifiers (11) to biosensing devices 
(12-14). The most commonly studied amphiphilic lipids which form LCPs are the cis-
unsaturated monoacylglycerols (MAGs), which are a distinctive class of lipids that can form 
various lyotropic liquid crystalline phases with different inverse geometries. These phases, and 
their transitions, can be affected by tuning hydration and temperature (15). Most importantly, 
they are known to form inverse bicontinuous LCPs in excess of water and room temperature.  
Despite remarkable recent advances in the field, there are only a few lipids that are known to 
form LCPs. As discussed in chapter 1 of this thesis, the conformation of the lipidic bilayer is 
the result of the sum of a large number of attractive and repulsive intermolecular and 
mesophase-level interactions. Due to this complexity, it is not trivial to establish a clear 
relationship between the molecular properties of the lipids and the macroscopic properties of 
the ensuing mesophases (16). The size and nature of the head group, together with the length 
and curvature of the chain, govern the packing arrangements of the molecules within the lipidic 
bilayer and therefore the phase transitions of amphiphilic aggregates in general. For the 
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monoacylglycerols in particular, the chain splay (Figure 1) was shown to have an essential role 
in effecting the phase and structural behavior, with an increased stability of negatively curved 
phases increasing the chain splay (17). Thus, it is important to understand the polymorphism of 
lipidic nanostructures on a molecular level by investigating the driving forces of amphiphilic 
self-assembly, phase transitions and phase behavior. This can be achieved through the design 
and synthesis of novel amphiphilic lipids with small variations in the hydrophobic region. 
 
Figure 1. The molecular structure of the most common MAGs in increasing order of chain splay: (a) 1-
monoelaidin (ME), (b) monovaccenin (MV), (c) monoolein (MO), (d) monolinolein (ML). 
 
This study has taken inspiration from naturally occurring molecules, namely cyclopropanated 
phospholipids. These lipids are found with widespread distribution amongst bacteria. In the 
case of gram negative bacteria, cyclopropanated lipids have been found in both the inner and 
the outer membrane. This chemical phenomenon is highly conserved amongst various bacteria. 
Together with the high energetic cost of the cyclopropanation reaction this suggests that these 
lipids play an important biological role, which is still not completely understood. Significantly, 
it has been shown that the presence of cyclopropanated phospholipids improves the survival 
ability of bacterial pathogens like M. tuberculosis (18), and enhances the resistance of the E. 
coli cell membrane to acid and cold shock (19). They also appear to have an important role in 
regulating membrane fluidity and bilayer thickness (20). 
In this thesis, the most intensely studied, naturally occurring cis-monoacylglycerols have been 
modified by replacing the olefin with a rigid cyclopropyl moiety, thereby obtaining a small 
library of novel target lipids that exhibit a subtle variation in the alkyl chain region, where the 
cis-double bonds of traditional MAGs have been replaced with a cis-cyclopropane moiety 
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(Figure 2). The cyclopropyl ring has chemical properties similar to a double bond due to its 
strained conformation and the distortion of its orbitals. Most importantly for our system, the 
general curvature of the target molecules is similar to that of the cis-MAGs due to the similar 
angle of the two functional groups, albeit the added methylene group protrudes out of the plane 
of the molecule, creating a kink on the molecular structure and consequently locking the cis 
geometry.  
 
Figure 2. Designed cyclopropaneted analogous of the most common MAGs. 
 
Lipidated ClC inhibitor 
Chloride channels (ClC) are a class of membrane proteins essential for transport and diffusion 
of Cl- ions across the cell membranes (21). This important class of membrane proteins will be 
described in greater detail in chapter 5 of this thesis. ClCs are present in all kingdoms of life, 
and their highly conserved structure make this family interesting from structural and 
mechanistic point of view (22-24). Moreover, in the last 25 years, nine different ClC 
homologues were discovered in humans and subsequently linked to numerous hereditary 
diseases. Malfunction of different ClCs is related to myotonia congenita, osteoporosis, Dent’s 
disease and Bartter’s syndrome disease (23). Even though ClC proteins represent potentially 
important drug targets, there is a lack of selective, potent inhibitors or activators of these 
proteins (25). Few inhibitors are known to be active on several ClCs, for example, 5-nitro-2-(3-
phenylpropylamino) benzoic acid (NPPB), propionic acid (CPP) and the general ClC blocker 
4,4′-diisothiocyanostilbene2,2′-disulfonic acid (DIDS), which highlights the need to further 
investigate the mechanism of action of these membrane proteins in health and disease, and how 
they can be blocked. The high resolution structure of the medically important complexes 
between the ClC transporter and any of its inhibitors is unknown, as is the mode of binding and 
mechanism of inhibition. In order to understand, control and manipulate these vital proteins, a 
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novel inhibitor was designed and synthesized with differing degrees of hydrophobicity, in order 
to utilize these lipophilic inhibitors, incorporated into LCPs, for the crystallization of the 
complex with EcClC. 
The molecular design of the novel inhibitor is based on the well-established inhibitor, DIDS, 
which has been shown to be unstable in water (26), undergoing hydrolysis to 4,4′-
diaminostilbene-2,2′-disulfonic acid (DADS), a molecule which does not have an effect on the 
activity of ClCs. 
 
Figure 3. Chemical structure of diaminostilbene-2,2′-disulfonic acid (DADS). 
 
However, its polymerization products are potent inhibitors, whose affinity to the protein 
increases with their molecular weight (Figure 4). In a recent study, a novel inhibitor (4,4'-
octanamidostilbene-2,2'-disulfonate, OADS) with higher affinity than DIDS was synthesized 
(27).  
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Figure 4. Chemical structures of ClC-ec1 inhibitors: DIDS, OADS, and the pentameric product of the 
hydrolysis and polymerization of DIDS. 
 
The strategy taken in this study was to increase the molecular weight of DADS by anchoring 
lipidic tails to it (Figure 5), thereby enhancing the lipophilicity of the molecule and 
consequently, its probability of partitioning into the bilayer of the mesophase. It was 
hypothesized that the immobilization of the alkylated inhibitor may have the additional 
advantage of improving the ability to crystalize the complex protein- inhibitor from the LCPs.  
 
Figure 5. Lipidation of DADS to generate  new, potential EcClC inhibitors able to be solubilized and 
incorporated in the lipidic bilayer of LCPs . 
 
2.1 Results and discussion 
2.1.1 Synthesis cyclopropanated lipids 
Four different cyclopropanated lipids were designed and synthesized: monodihydrosterculin 
(MDS) (28), cyclopropyl monopalmitolein (CPMP), monolactobacillin (MLB), and 
dicyclopropyl monolinolein (DCPML) as shown in Figure 2. The hypothesis underlying these 
studies is that the rigidity of the lipidic tail can be modulated by changing the number and the 
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position of the cyclopropyl group and the length of the hydrophobic chains, as shown 
schematically in Figure 6.  
Starting from lipids that are known to form lipidic cubic phase, the cis double bond was 
systematically replaced by a geometrically confined cyclopropyl ring. The members of this 
synthesized family differ in terms of:  
 the number of the cyclopropyl groups: one or two (corresponding to monoolein vs 
monolinolein),  
 the position of the cyclopropanation: C9 or C11 (corresponding to monoolein vs 
monovaccenin),  
 and the chain length: C18 or C16 with a cyclopropyl group in the C9 position 
(corresponding to monoolein vs monopalmitolein).  
 
Figure 6. Designed cyclopropanated MAGs that have been synthesized.  
 
Three synthetic routes were attempted for each one of the target lipids in order to optimize the 
yields for the different products starting from the commercially available corresponding acid 1 
(Figure 7). Cyclopropanation of olefin 1 was carried out with diethyl zinc and diiodomethane 
in the presence of 2,4,6-trichlorophenol according to a method previously described in the 
literature (29) to afford the corresponding cyclopropanaated acid 2 in 65-75 % yield. 
The acid 2 was subsequently used to obtain the corresponding desired product using three 
different routes as shown in Figure 7. 
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Figure 7. Various strategies employed to optimize the synthesis of cyclopropanated MAGs. 
 
As a first attempt, the acid 2 was reacted with glycerol in the presence of N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and 4-
(dimethylamino)pyridine (DMAP) in dichloromethane to afford the desired ester 3 in 68-78% 
yield. The latter was then hydrolyzed in a solution of H2SO4 in acetone to obtain the desired 
product 4.  
Following the second approach, the acid 2 was reacted with a large excess of glycerol in the 
presence of EDC and DMAP in dichloromethane to afford the desired ester 4 in 43-48% yield. 
Due the low solubility of glycerol in dichloromethane the second route was modified by 
changing the solvent to dimethylformamide (DMF), resulting in increase of the yield up to 69-
76%. 
2.1.2 Synthesis of DADS derivatives 
The synthesis of OADS and the oleic derivative of DADS was accomplished in one step starting 
from commercially available DADS (Figure 8). Alkylation of DADS was carried out with 
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octanoyl chloride or oleoyl chloride in dry pyridine according to a method previously described 
in the literature (30, 31), to afford the desired product in 90% yield. In the case of OADS, the 
product was solubilized in CH3CN, and the filtrate solubilized again in CH2Cl2. In the case of 
the oleic derivative of DADS, the product was precipitated in CH3CN, washed in CH3CN and 
solubilized in CH2Cl2. The products were characterized by 1H NMR.  
Alternative strategies for the alkylation were attempted. Firstly, DADS was reacted with EDC, 
DMAP and the corresponding acid in Et2O/CH2Cl2, but due the low solubility of DADS no 
product was formed. In addition, a reaction of DADS with NaCO3 and the corresponding acyl 
chloride for 24h in a mixture of H2O and dioxane was also attempted, obtaining a yield lower 
than 10%. 
 
 
Figure 8. Synthesis of DADS derivatives with octanoyl chloride or oleoyl chloride in dry pyridine, 12 
min, T reflux., 90%. 
 
2.2 Materials and methods  
Glycerol anhydrous was purchased from Fluka, diethyl zinc was purchased from Acros 
Organics, EDC was purchased from TCI, and all the other reagents and solvents were purchased 
from Sigma Aldrich or VWR. All chemicals and solvents were used as received, unless 
otherwise stated. Reactions were carried out under an inert atmosphere of argon in dry solvents. 
Dichloromethane was degassed with argon and purified by passage through activated alumina 
solvent column (MC Brown solvent system) prior to use. Column chromatography was 
performed using silica gel Merck 60 (particle size 0.040–0.063 mm). Analytical thin-layer 
chromatography (TLC) was performed using Merck pre-coated silica gel plates 60 F254; 
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visualization by UV absorption and/or by dipping in a solution of KMnO4 (1 g), K2CO3 (2 g) 
in H2O (100 mL) and subsequent heating. 1H-NMR spectra were recorded on a Bruker AV2-
500 (500MHz) spectrometer. Chemical shifts are given in parts per million (ppm) relative to 
the solvent residual peak: CDCl3 = 7.26 ppm. Coupling constants J are expressed in Hz and 
multiplicities are abbreviated as follows: s (singlet), br (broad), d (doublet), t (triplet), q 
(quadruplet), quint (quintet), m (multiplet). 13C-NMR chemical shifts are reported relative to 
the solvent residual peaks: CDCl3 = 77.23 ppm. High-resolution electrospray mass spectra were 
performed on a Bruker maXis QTOF-MS instrument. A mass accuracy 2 ppm was obtained 
in the peak-matching acquisition mode. 
 
Synthesis of 1-(cis-9,10-methylene-octadecanoyl)-rac-glycerol (compound 4a (MDS)) 
 
8-(2-octylcyclopropyl)octanoic acid (dihydrosterculic acid) (2a)  
To a stirred solution of 2,4,6-trichlorophenol (8.60 g, 43.5 mmol) in 200 mL of dry CH2Cl2 at -
40 °C under argon was added a 1 M hexane solution of diethyl zinc (44 mL, 44 mmol). The 
solution was stirred for 15 min at -40 °C and then diiodomethane (11.66 g, 3.50 mL, 43.5 mmol) 
was slowly added over a period of 10 min. After stirring for 15 min at the same temperature 
oleic acid 1a (3.07 g, 3.47 mL, 10.88 mmol) was added. The reaction mixture was stirred at -
40 oC for an additional 1 h and then allowed to warm to rt and stirred overnight. The mixture 
was washed with 300 mL of 10 % HCl. The organic phase was separated and the aqueous phase 
was extracted with CH2Cl2 (3 x 150 mL). The combined organic phases were washed with a 
saturated solution of NaCl and dried over MgSO4. The solvent was removed under reduced 
pressure and the residue was purified by column chromatography on silica gel eluted with a 
mixture CH2Cl2/MeOH 95:5. The solvent was evaporated to afford a yellow oil (2.4 g), which 
was precipitated with cold acetonitrile to afford compound 2a as a white solid (2.1 g, 65%). 
 
HRMS (ESI [M + Na]+ ) m/z: calcd for (C19H36NaO2) 319.26074, found 319.26075. 
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1-(cis-9,10-methylene-octadecanoyl)-rac-glycerol (MDS) (4a) 
To a stirred solution of acid 2a (660 mg, 2.23 mmol) in 50 mL of dry CH2Cl2/DMF (3:1) was 
added EDC (556 mg, 2.90 mmol) followed by DMAP (27 mg, 0.223 mmol) at 0 °C under argon. 
The solution was stirred for 1 h at 0 °C and then was added dropwise over a period of 30 min 
to a solution of glycerol (1.23 g, 13.38 mmol) in 50 mL of dry DMF at 0 °C. The mixture was 
stirred for 12 h at room temperature and then washed with a saturated solution of NaHCO3. . 
The organic phase was separated and the aqueous phase was extracted with CH2Cl2 (3 x 100 
mL). The combined organic phases were washed with brine and dried over MgSO4. The solvent 
was removed under reduced pressure and the residue was purified by column chromatography 
on silica gel and eluted with a mixture of cyclohexane/ethylacetate 8:2 to 4:6. The solvent was 
evaporated to afford a yellow oil (630 mg), which was precipitated with cold acetonitrile to 
afford a yellow solid which was then purified by low-temperature crystallization in acetonitrile 
(-20 °C to 4 °C) to yield 570 mg of 1-MDS 4a as a white solid (69%), mp: 27 °C. 
 
1H NMR (500 MHz, CDCl3) δ 4.22 (dd, J = 11.7, 4.6 Hz, 1H), 4.16 (dd, J = 11.7, 6.2 Hz, 
1H), 3.94 (tt, J = 6.0, 4.3 Hz, 1H), 3.86 – 3.84 (m, 0H), 3.71 (dd, J = 11.4, 4.0 Hz, 1H), 3.61 
(dd, J = 11.4, 5.8 Hz, 1H), 2.42 – 2.33 (m, 2H), 1.97 (br, 2H) 1.68 – 1.60 (m, 2H), 1.45 – 1.22 
(m, 23H), 1.21 – 1.09 (m, 2H), 0.94 – 0.85 (m, 3H), 0.70 – 0.62 (m, 2H), 0.60 – 0.54 (m, 1H), 
-0.33 (td, J = 5.3, 4.0 Hz, 1H). 
13C NMR (125 MHz, CDCl3)  174.40, 170.29, 70.29, 65.18, 63.33, 34.17, 31.94, 30.23, 
30.14, 29.70, 29.45, 29.38, 29.31, 29.15, 28.73, 28.67, 24.92, 22.71, 15.77, 15.72, 14.14, 
10.92; HRMS (ESI [M + Na]+ ) m/z: calcd for (C22H42NaO4) 393.29749, found 393.29753. 
 
Synthesis of 1-(cis-9,10-methylene-esadecanoyl)-rac-glycerol (compound 4b (CPMP)) 
 
8-(2-hexylcyclopropyl)octanoic acid (CP-palmitoleic acid) (2b) 
To a stirred solution of 2,4,6-trichlorophenol (8.60 g, 43.5 mmol) in 250 mL of dry CH2Cl2 at 
-40 °C under argon was added a 0.9 M hexane solution of diethyl zinc (49 mL, 44 mmol). The 
solution was stirred for 15 min at -40 °C and then diiodomethane (11.66 g, 3.50 mL, 43.5 mmol) 
was slowly added over a period of 10 min. After stirring for 15 min at the same temperature, 
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palmitoleic acid 1b (2.77 g, 3.10 mL 10.88 mmol) was added. The reaction mixture was stirred 
at -40 oC for an additional 1 h and then allowed to warm to r.t. and stirred overnight. The 
mixture was washed with 300 mL of 10 % HCl. The organic phase was separated and the 
aqueous phase was extracted with CH2Cl2 (3 x 150 mL). The combined organic phases were 
washed with a saturated solution of NaCl and dried over MgSO4. The solvent was removed 
under reduced pressure and the residue was purified by column chromatography on silica gel 
eluted starting with CH2Cl2, and after elution of excess 2,4,6-trichlorophenol with 
CH2Cl2/MeOH 95:5 to get the product 2b as a slightly yellow oil (2.13 g, 73%). 
 
1H NMR (500 MHz, CDCl3) δ 2.28 (t, J = 7.5 Hz, 2H), 1.57 (q, J = 7.5 Hz, 2H), 1.14 – 1.36 
(m, 18H), 1.01 – 1.12 (m, 2H), 0.82 (t, J = 7.0 Hz, 3H), 0.46 – 0.62 (m, 3H), - 0.39 - -0.42 (m, 
1H).  
13C-NMR (125 MHz, CDCl3) 179.22, 33.91, 31.95, 30.18, 30.12, 29.42, 29.34, 29.28, 29.07, 
28.72, 28.66, 24.70, 22.69, 15.77, 15.73, 14.11, 10.91. 
HRMS (ESI [M - H]-) m/z: calcd for (C17H31O2) 267.23295, found 267.23271. 
 
1-(cis-9,10-methylene-esadecanoyl)-rac-glycerol (CPMP) (4b) 
To a stirred solution of acid (600 mg, 2.23 mmol) in 50 mL of a mixture of dry CH2Cl2/DMF 
(3:1) was added EDC (556 mg, 2.90 mmol) followed by DMAP (27 mg, 0.223 mmol) at 0 °C 
under argon. The solution was stirred for 1 h at 0 °C and then was added dropwise over a period 
of 30 min to a solution of glycerol (1.23 g, 13.38 mmol) in 50 mL of dry DMF at 0 °C. The 
mixture was stirred for 12 h at room temperature and then washed with a saturated solution of 
NaHCO3. The organic phase was separated and the aqueous phase was extracted with CH2Cl2 
(3 x 100 mL). The combined organic phases were washed with brine and dried over MgSO4. 
The solvent was removed under reduced pressure and the residue was purified by column 
chromatography on silica gel and eluted with a mixture of cyclohexane/ethylacetate 8:2 to 4:6. 
The solvent was removed to give colourless solid product 4c (420 mg, 55%). 
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1H-NMR (500 MHz, CDCl3) δ 4.86 (quint, J = 4.7 Hz, 1H of 2-NMH), 4.13 (dd, J = 11.7, 4.6 
Hz, 1H), 4.08 (dd, J = 11.6, 6.2 Hz, 1H), 3.84 – 3.89 (m, 1H), 3.76  (t, J = 5.2 Hz, 4H of 2-
NMH), 3.59 – 3.68 (m, 1H), 3.50 – 3.56 (m, 1H), 2.64 (br d, OH), 2.26 – 2.34 (m, 2H), 2.18 – 
2.25 (m, 1 H), 1.52 – 1.60 (m, 2H), 1.14 – 1.35 (m, 18H), 1.01 – 1.12 (m, 2H), 0.82 (t, J = 6.8 
Hz, 3H), 0.46 – 0.62 (m, 3H), -0.40 (q, J = 5.1 Hz, 1H). 
13C-NMR (125 MHz, CDCl3) δ 174.34, 70.27, 65.16, 63.35, 34.15, 31.94, 30.16, 30.11, 29.42, 
29.33, 29.28, 29.13, 28.71, 28.65, 24.91, 22.68, 15.76, 15.71, 14.10, 10.91. 
HRMS (ESI [M + Na]+) m/z: calcd for (C20H38O4Na) 365.26623, found 365.26647 
 
Synthesis of 1-(cis-11,12-methylene-octadecanoyl)-rac-glycerol (compound 4c (MLB)) 
 
10-(2-hexylcyclopropyl)decanoic acid (Lactobacillic acid) (2c) 
To a stirred solution of 2,4,6-trichlorophenol (8.60 g, 43.5 mmol) in 200 mL of dry CH2Cl2 at 
-40 °C under argon was added a 0.9 M hexane solution of diethyl zinc (49 mL, 44 mmol). The 
solution was stirred for 15 min at -40 °C and then diiodomethane (11.66 g, 3.50 mL, 43.5 mmol) 
was slowly added over a period of 10 min. After stirring for 15 min at the same temperature 
vaccenic acid 1c (3.07 g, 3.46 mL, 10.88 mmol) was added. The reaction mixture was stirred 
at -40 oC for an additional 1 h and then allowed to warm to r.t. and stirred overnight. The 
mixture was washed with 300 mL of 10 % HCl. The organic phase was separated and the 
aqueous phase was extracted with CH2Cl2 (3 x 150 mL). The combined organic phases were 
washed with a saturated solution of NaCl and dried over MgSO4. The solvent was removed 
under reduced pressure and the residue was purified by column chromatography on silica gel 
eluted starting with CH2Cl2, and after elution of excess 2,4,6-trichlorophenol with 
CH2Cl2/MeOH 95:5 to get the product 2c as colourless solid (2.29 g, 71%). 
 
1H-NMR (500 MHz, CDCl3) δ 2.28 (t, J = 7.5 Hz, 2H), 1.56 (quint, J = 7.4 Hz, 2H), 1.14 – 
1.37 (m, 22H), 1.01 – 1.15 (m, 2H), 0.82 (t, J = 6.9 Hz, 3H), 0.47 – 0.61 (m, 3H), -0.40 (q, J = 
5.1 Hz, 1H).  
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13C-NMR (125 MHz, CDCl3) δ 179.63, 33.97, 31.95, 30.19 (2C), 29.63 (2C), 29.44, 29.36, 
29.25, 29.07, 28.73, 28.71, 24.69, 22.70, 15.77, 15.76, 14.12, 10.91. 
HRMS (ESI [M - H]-) m/z: calcd for (C19H35O2) 295.26425, found 295.26394. 
 
1-(cis-11,12-methylene-octadecanoyl)-rac-glycerol (MLB) (4c) 
To a stirred solution of acid (660 mg, 2.23 mmol) in 50 mL of a mixture of dry CH2Cl2/DMF 
(3:1) was added EDC (556 mg, 2.90 mmol) followed by DMAP (27 mg, 0.223 mmol) at 0 °C 
under argon. The solution was stirred for 1 h at 0 °C and then was added dropwise over a period 
of 30 min to a solution of glycerol (1.23 g, 13.38 mmol) in 50 mL of dry DMF at 0 °C. The 
mixture was stirred for 12 h at room temperature and then washed with a saturated solution of 
NaHCO3. The organic phase was separated and the aqueous phase was extracted with CH2Cl2 
(3 x 100 mL). The combined organic phases were washed with brine and dried over MgSO4. 
The solvent was removed under reduced pressure and the residue was purified by column 
chromatography on silica gel and eluted with a mixture of cyclohexane/ethylacetate 8:2 to 4:6. 
The solvent was removed to give the product 4c (480 mg, 58%) as a slightly yellowish oil. 
 
1H-NMR (500 MHz, CDCl3) δ 4.86 (quint, 1H of 2-MLB), 4.13 (dd, J = 11.7, 4.7 Hz, 1H), 
4.09 (dd, J = 11.7, 6.1 Hz, 1H), 3.83 – 3.89 (m, 1H), 3.75 – 3.78 (m, 4H of 2-MLB), 3.62 (dd, 
J = 11.4, 4.0 Hz, 1H), 3.53 (dd, J = 11.5, 5.8 Hz, 1H), 2.24 – 2.35 (m, 2H), 2.04 (br s, 2H, OH), 
1.52 – 1.61 (m, 2H), 1.15 – 1.37 (m, 22H), 1.01 – 1.12 (m, 2H), 0.82 (t, J = 7.8 Hz, 3H), 0.45 
– 0.67 (m, 3H), -0.35 – -0.46 (m, 1H). 
13C-NMR (125 MHz, CDCl3) δ 174.34, 70.26, 65.16, 63.32, 34.15, 31.94, 30.19, 30.17, 29.62 
(2C), 29.45, 29.34, 29.24, 29.13, 28.71, 28.70, 24.91, 22.69, 15.76, 15.74, 14.12, 10.90. 
HRMS (ESI [M + Na]+) m/z: calcd for (C22H42O4Na) 393.29753, found 393.29757. 
 
Synthesis of 1-(cis-9,10,12,13-dimethylene-octadecanoyl)-rac-glycerol (compound 4d 
(DCPML)) 
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8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoic acid (CP-linoleic acid) (2d) 
To a stirred solution of 2,4,6-trichlorophenol (8.60 g, 43.5 mmol) in 200 mL of dry CH2Cl2 at 
-40 °C under argon was added a 0.9 M hexane solution of diethyl zinc (49 mL, 44 mmol). The 
solution was stirred for 15 min at -40 °C and then diiodomethane (11.66 g, 3.50 mL, 43.5 mmol) 
was slowly added over a period of 10 min. After stirring for 15 min at the same temperature 
linoleic acid 1d (1.53 g, 1.70 mL, 5.44 mmol) was added. The reaction mixture was stirred at -
40 oC for an additional 1 h and then allowed to warm to r.t. and stirred overnight. The mixture 
was washed with 300 mL of 10 % HCl. The organic phase was separated and the aqueous phase 
was extracted with CH2Cl2 (3 x 150 mL). The combined organic phases were washed with a 
saturated solution of NaCl and dried over MgSO4. The solvent was removed under reduced 
pressure and the residue was purified by column chromatography on silica gel eluted starting 
with CH2Cl2, and after elution of excess 2,4,6-trichlorophenol with CH2Cl2/MeOH 95:5 to get 
the product 2d as a slightly yellow oil (1.16 g, 69%). 
Mixture of diastereoisomers: 
1H-NMR (500 MHz, CDCl3) δ 2.28 (t, J = 7.5 Hz, 1H), 1.51 – 1.62 (m, 2H), 1.17 – 1.46 (m, 
17H), 0.91 – 1.15 (m, 3H), 0.82 (t, J = 6.8 Hz, 3H), 0.67 – 0.75 (m, 2H), 0.51 – 0.66 (m, 4H), -
0.30 – -0.40 (m, 2H). 
13C-NMR (125 MHz, CDCl3) δ 179.90, 34.06, 31.90, 30.13, 29.89, 29.42, 29.30, 29.08, 28.88, 
28.87, 28.72, 28.70, 28.02, 27.87, 24.70, 22.72, 16.05, 15.93, 15.91, 15.88, 15.66, 15.61, 14.12, 
11.02, 10.84. 
HRMS (ESI [M - H]-) m/z: calcd for (C20H35O2) 307.26425, found 307.26407. 
 
1-(cis-9,10,12,13-dimethylene-octadecanoyl)-rac-glycerol (DCPML) (4d) 
To a stirred solution of acid (688 mg, 2.23 mmol) in 50 mL of a mixture of dry CH2Cl2/DMF 
(3:1) was added EDC (556 mg, 2.90 mmol) followed by DMAP (27 mg, 0.223 mmol) at 0 °C 
under argon. The solution was stirred for 1 h at 0 °C and then was added dropwise over a period 
of 30 min to a solution of glycerol (1.23 g, 13.38 mmol) in 50 mL of dry DMF at 0 °C. The 
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mixture was stirred for 12 h at room temperature and then washed with a saturated solution of 
NaHCO3. The organic phase was separated and the aqueous phase was extracted with CH2Cl2 
(3 x 100 mL). The combined organic phases were washed with brine and dried over MgSO4. 
The solvent was removed under reduced pressure and the residue was purified by column 
chromatography on silica gel and eluted with a mixture of cyclohexane/ethylacetate 8:2 to 4:6. 
The solvent was removed to give the product 4d (605 mg, 71%) as a slightly yellowish oil. 
 
1H NMR (400 MHz, CDCl3) δ 4.86 (quint, J = 4.8 Hz, 1H of 2-MBMO), 4.13 (dd, J = 11.7, 
4.7 Hz, 1H), 4.09 (dd, J = 11.6, 6.1 Hz, 1H), 3.83 – 3.90 (m, 1H), 3.75 – 3.78 (m, 4H of 2-
MBMO), 3.62 (dd, J = 11.5, 4.0 Hz, 1H), 3.54 (dd, J = 11.5, 5.8 Hz, 1H), 2.25 – 2.34 (m, 2H), 
2.18 (br s, 2H, OH), 1.52 – 1.61 (m, 2H), 1.17 – 1.47 (m, 17H), 0.91 – 1.13 (m, 3H), 0.82 (t, J 
= 7.0 Hz,  3H), 0.68 – 0.77 (m, 2H), 0.51 – 0.65 (m. 4H) -0.29 – -0.39 (m, 2H). 
13C-NMR (125 MHz, CDCl3) δ 174.34, 70.25, 65.13, 63.32, 34.14, 31.88, 30.11, 29.87, 29.41, 
29.28, 29.12, 28.86, 28.84, 28.69, 28.68, 28.01, 27.85, 24.90, 22.70, 16.03, 15.91, 15.91, 15.89, 
15.85, 15.64, 15.58, 14.10, 11.01, 10.82. 
HRMS (ESI [M + Na]+) m/z: calcd for (C23H42O4Na) 405.29753, found 405.29715. 
 
Synthesis of 4,4'-octanamidostilbene-2,2'-disulfonate, OADS 
To a stirred solution of DADS (1g, 2.7 mmol) in 50 mL of dry pyridine at reflux temperature 
under argon was added oleoyl chloride (1.84 ml, 1.75g, 10.8 mmol) dropwise. The solution was 
stirred for 40 min, then transferred to a single neck flask and the solvent was evaporated under 
reduced pressure. The crude product was dissolved in hot CH3CN and then twice precipitated 
at 4 oC. The precipitated red crystals were filtered, the solvent was removed under reduced 
pressure, and the product extracted with CHCl3. The solvent was removed under reduced 
pressure to obtain the desired product OADS 6 as an orange solid (1.5g, 90%).  
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Synthesis of 4,4'-oleamidostilbene-2,2'-disulfonate 
To a stirred solution of DADS (200 mg, 0.54 mmol) in 10 mL of dry pyridine at reflux 
temperature under argon was added oleoyl chloride (0.72 ml, 650mg, 2.16 mmol) dropwise, 
after which the solution becomes immediately transparent. The solution was stirred for 15 min, 
then transferred to a single neck flask and the solvent was evaporated under reduced pressure. 
The crude product was dissolved in hot CH3CN and then twice precipitated at 4 oC. The 
resultant yellow oil was dissolved in CH2Cl2, the precipitate was removed by filtration. The 
solvent was removed under reduced pressure to obtain the desired product 7 as slightly 
yellowish solid (0.44g, 90%).  
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Chapter 3 
 
Phase behavior of designed cyclopropyl analogues of the 
most commonly investigated monoacylglycerols. 
 
 
Most nanostructured lipidic materials used in biomedical applications to date are based on 
naturally or commercially available lipids, mainly monoacylglycerols 
(MAGs).  Monoacylglycerols are a unique class of lipids, which show a complex polymorphism 
upon hydration (Figure 1). By changing the ratio of lipid to water, they exhibit specific 
transitions between lyotropic liquid crystalline phases with various inverse geometries (1). With 
an increasing amount of water at ambient temperatures, the typical sequence of the most 
commonly studied MAGs, monoolein (MO) and monolinolein (MLO) is: lamellar crystalline 
(Lc), liquid crystalline lamellar (Lα), bicontinuous cubic (Ia3d and Pn3m), while at high 
temperatures (80-90℃) is inverse micellar phase (L2) and inverse hexagonal phase (HII) (2). In 
addition to the variation of hydration, environmental factors such as temperature and pressure 
affect phase stability and control the formation of various phases with defined material 
properties (1, 3-5). The geometry and the structure of these phases have been well-established 
(2, 6), and the curvature of the channel is a characteristic parameter of lipidic phases, with the 
highest curvature associated with the high-temperature phases.  
 
 
 
Figure 1. Sequence of phases generally formed by monoacylglicerols upon hydration. From left to right: 
lamellar Lα, bicontinuous cubic Ia3d, Pn3m, Im3m, inverse micellar phase L2 and inverse hexagonal HII.  
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Both the Lc and Lα phases consist of an alternation of a planar lipidic bilayer and a layer of 
water, but while Lc is a solid phase organized in a crystalline lattice, Lα is a liquid crystalline 
phase that flows like a viscous liquid albeit according to an internal crystalline order. Cubic 
phases are made out of one curved lipidic bilayer arranged in an infinite periodic minimal 
surface that encompasses two identical, but not interconnected water channels (7). The type of 
surface symmetry can vary forming different cubic phases with gyroid (Ia3d), double diamond 
(Pn3m), or primitive symmetry (Im3m). In the inverse hexagonal phase, the lipidic molecules 
assemble into inverse micellar cylinders that are packed in a hexagonal lattice. Among these 
geometries, the inverse bicontinuous cubic phases are of particular interest as bio-inspired 
matrices in several fundamental and applied scientific disciplines such as membrane biology 
(3, 8-11), drug delivery (12-14), food emulsifiers (15) and biosensing devices (16-18). This is 
due to their high interfacial surface area, three-dimensional continuous hydrophilic and 
hydrophobic regions and thermodynamic stability in excess of water.  
The inverse hexagonal phase is also being intensively studied as intermediate in membrane 
fusion and as drug delivery system due its stability in excess of water, and its capacity to 
solubilize drugs in a similar manner to the cubic phases. Moreover, dispersed inverse hexagonal 
phases show a slower release profile than dispersed cubic phase (19). Unfortunately, the 
availability of pure lipids demonstrating a stable inverse hexagonal phase in excess water at 
physiological temperature is limited to few examples such as phosphatidylethanolamines (20, 
21), 1-glyceryl monooleyl ether (22) and glycerate surfactants (23). Alternatively, they are 
formed by mixing MAGs or phytantriol with a hydrophobic additive (24, 25). 
The increasing scope of applications of LCPs in various biomedical areas often requires the 
ability to tune the nanoscopic and macroscopic properties of LCPs to the required use. For 
instance, the mesophase geometry determines the release rate of encapsulated drugs (13, 14, 
19, 26-28), as well as the thermostability (29). In addition to molecular geometry, the ability of 
the mesophase to incorporate different amounts of water and the thickness of the lipidic bilayer 
determines the utility of the mesophase for protein crystallization (30, 31). For membrane 
protein crystallization (8) in particular, the screening of alternative lipids has been shown to be 
a valid method for crystal optimization (32). 
Clearly, control of the molecular features of the lipid determines the properties of the 
nanostructure and thus can empower numerous technological applications of lipidic mesoscopic 
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materials. Consequently, the design and construction of a matrix with a specific geometry and 
phase behavior requires availability of new basic molecular motifs and rigorous phase 
characterization to elucidate the relationship between the structure and properties. The position 
of the cis-double bond in the chain, and head group modification, especially charged ones, are 
known to influence curvature and hence phase behavior (33). In this thesis, a family of novel 
lipids with discrete variations in the hydrophobic region has been designed and synthesized, 
and subsequently their phase behavior established in order to understand how subtle molecular 
changes of the lipid structure can be used to influence the balance of mesophases formed.  
In this work we have modified the most intensely studied MAGs, monoolein (MO), 
monopalmitolein (MP), monovaccein (MV) and monolinolein (ML), replacing the olefin with 
a rigid cyclopropyl moiety to obtain a novel family of designed lipids: monodihydrosterculin 
(MDS), cyclopropyl monopalmitolein (CPMP), monolactobacillin (MLB), dicyclopropyl 
monolinolein (DCPML). Each one of these lipids shows a subtle variation in the alkyl chain, 
where the cis-double bond of a traditional monoacylglycerol has been replaced with a cis-
cyclopropane. The ability of cyclopanated lipids to protect the bacterial membrane from acid 
and cold shock together with the chemical and geometrical effect of a cyclopropyl ring on the 
lipidic chain are described in chapter 2 of this thesis together with the synthetic routes of these 
target lipids. Their structure and the structure of the corresponding unsaturated 
monoacylglicerols are depicted again in Figure 2. 
 
Figure 2. Top row: chemical structure of common unsaturated monoacylglycerols. From left to right: 
monoolein (MO), monopalmitolein (MP), monovaccein (MV) and monolinolein (ML). Bottom row: 
chemical structure of the synthesized cyclopropaneted monoacylglicerols. From left to right: 
monodihydrosterculin (MDS), cyclopropyl monopalmitolein (CPMP), monolactobacillin (MLB), 
dicyclopropyl monolinolein (DCPML). 
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In order to characterize the effect of the cyclopropyl moiety on the phase diagram of these novel 
lipids, their aqueous and thermal phase behavior were studied with small-angle X-ray scattering 
(SAXS). 
3.1 Results and discussion 
3.1.1 Phase diagrams  
Full phase diagrams for the four target MAGs were established by SAXS, which is the method 
of choice to investigate the temperatures and compositions at which order-to-order transitions 
occur. The four phase diagrams (Figures 3, 5-7) of the cyclopropanated lipids are shown 
overlaid on the phase diagrams of the corresponding cis-olefinic MAGs.  
The first cyclopropanated system studied was MDS (29). At temperatures below 30°C, the 
binary MDS:H2O phase diagram features order-to-order transitions from the Lα to Ia3d, and 
from Ia3d to Pn3m upon hydration, and finally formation of the fully hydrated Pn3m cubic 
phase above a characteristic boundary of full hydration (Figure 3). At high temperatures, all 
phases transform into the isotropic L2 phase. The sequence of transitions between the 
mesophases is similar to that of MO, while the temperature and hydration range of the order-
to-order transition differ. Significantly, the high-temperature HII phase that appears in MO (2, 
6) is absent in the corresponding cyclopropanated system. The highly curved HII phase has the 
highest packing frustration energy, and its absence may be correlated with a difference in the 
chain stretching energy due to the new hydrophobic motif (34).  
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 Figure 3.  Overlay of the binary phase diagrams of MDS (solid lines) and MO (background, light grey) 
adapted from H. Qiu, M. Caffrey (2). Sample composition/temperature phase diagram of the MDS:water 
system was established by SAXS, taking into account evolution of the structural parameters in order to 
determine the mesophase and conditions of maximum hydration, and implicitly, the coexistence of the 
bulk phase with excess water. The phase diagram shows a series of order to order transitions with the 
following phase sequence: Lα (green) Lα+Ia3d (green+orange) Ia3d (orange) Ia3d+Pn3m 
(orange+blue) Pn3m (blue). Reproduced with permission from (29). 
 
The overlay of the binary phase diagrams of MDS and MO (Figure 3) reveals that at a given 
composition the transition temperature of any phase to the high-temperature L2 phase is lower 
in the MDS than in the MO system. The boundary lines between L2 and the lower-temperature 
phases in these two systems are not parallel, and form a wedge that broadens with increasing 
hydration: at low water content (5 %) the transition from Lα to L2 is isothermal (35 °C) in both 
systems. Upon increasing the water content, the MDS mesophases become increasingly less 
stable at high temperature, which is reflected in a relatively low transition temperature. 
Consequently, at 15 % water the Ia3d to L2 transition temperatures are 65 °C and 85 °C for the 
MDS and MO systems, respectively. 
The cubic-Ia3d is the most pronounced phase in both MO and MDS phase diagrams. For MDS, 
the Lα-Ia3d boundary is at lower water content than in MO, whereas the Ia3d-Pn3m boundary 
starts at lower hydration at a lower temperature, and ends at higher hydration at a higher 
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temperature. At even higher water content, the fully hydrated Pn3m phase is shifted to higher 
water content in MDS. Thus, the existence of the cubic phase for MDS is larger in the 
composition space, and smaller in the temperature space when compared to MO. 
The phase diagram of the MDS:H2O system (Figure 3) demonstrates a number of novel features 
that can be directly related to the molecular geometry of the hydrophobic chain, and its packing 
arrangement within various mesophases. As can be seen from the broader existence range of 
the cubic phases, the MDS system can accommodate more molecules of water in the cubic 
phase. Most importantly, this system, which possesses a rigid and more restricted cyclopropyl 
geometry, was shown to form curved cubic phases at lower temperature than the corresponding 
MO system, analogous to observed differences between corresponding 
phosphatidylethanolamines (35, 36). 
For a given phase at constant temperature, an increase in water content results in swelling, i.e. 
increase of the lattice size (Figure 4). For the Lα phase, the latter corresponds to the inter-
bilayer distance, that is, thickness of the aqueous compartment. For the cubic phases, this 
corresponds to the aqueous channel size. At a given temperature, there is a maximal hydration 
for a certain phase, above which coexistence with a maximally hydrated phase sets in. The 
coexistence region eventually transforms into the pure maximally hydrated phase upon further 
increase of water (Figure 4). In the coexistence region, the lattice parameter remains constant 
until a complete phase transition is accomplished (Figure 4B). Additionally, the curvature and 
the size variation of the lyotropic liquid crystalline unit cell are phase-dependent: the Lα and 
the cubic Pn3m have smaller lattice parameters, and the cubic Ia3d has larger lattice parameters 
(Figure 4B). 
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Figure 4. A) SAXS spectra of the scattered intensities versus scattering vector q, azimuthally averaged 
into 1D profiles, showing the structural evolution of the MDS:water system with increasing hydration 
at a constant temperature (30 °C). The spectra reveal a series of order to order transitions with the 
following phase sequence: Lα (green) Lα+Ia3d (beige) Ia3d (red) Ia3d+Pn3m (pale blue) 
Pn3m (blue), each phase being unequivocally characterized due to its unique diffraction peak ratios. B) 
Evolution of the lattice parameter size as a function of hydration for the different mesophases in the 
MDS:water system at 30 °C. Reproduced with permission from (29). 
 
Following the finding that the cyclopropyl moiety had a profound impact on the phase behavior 
due to its effect on the packing arrangement of the MAGs, the studies were expanded to the 
other three synthetic systems: MLB, CPMP, and DCPML. The phase diagrams of the singly 
cyclopropanated lipids CPMP (Figure 5) and MLB (Figure 6) present a sequence of phase 
transitions which is similar to their corresponding monoacylglycerols: the characteristic Lα 
phase at low water content, a transition to the cubic Ia3d, and subsequently from Ia3d to the 
cubic Pn3m upon hydration. In both cases, the Pn3m cubic phase was found to be stable in 
excess of water, and it was possible to determine a full hydration line in which the Pn3m phase 
coexists with pure water through the analysis of the lattice parameters at each level of hydration.  
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In the case of CPMP the boundaries are similar at low amount of water, but at room temperature 
the transition to Pn3m phase occurs at higher hydration level than in the corresponding 
unsaturated lipid MP. The high temperature behavior of this lipid was difficult to interpret 
because of a number interferences on the SAXS spectra.  Some peaks that do not belong to the 
Pn3m phase, are difficult to interpret and show low reproducibility were found in the 
temperature range above 80 ℃. The phase behavior up to 80 ℃ is reported in Figure 5. 
 
Figure 5. Overlay of the binary phase diagrams of CPMP (solid lines) and MP (background) adapted 
from J. Briggs’ PhD thesis, (The Ohio State University, Columbus, Ohio 1994). Sample 
composition/temperature phase diagram of the CPMP:water system was established by SAXS, taking 
into account evolution of the structural parameters in order to determine the phase maximum hydration, 
and implicitly coexistence of the bulk phase with excess water. The phase diagram shows a series of 
order to order transitions with the following phase sequence: Lα (green) Lα+Ia3d (green+orange) 
Ia3d (orange) Pn3m (blue). 
 
For the MLB system, the phase sequence is the same as that of the corresponding cis-
unsaturated lipid MV, but the phase boundaries are shifted in most of the cases to lower water 
content (Figure 6). Moreover, for MLB, the highly curved HII phase is present at high 
temperature, which was not observed in the phase behavior of MV. However, since the phase 
behavior of MV was characterized only up to 80 °C (37), its presence at higher temperatures 
cannot be excluded. 
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Figure 6.  Overlay of the binary phase diagrams of MLB (solid lines) and MV (background) adapted 
from Kulkarni et al. (37). Sample composition/temperature phase diagram of the MLB:water system 
was established by SAXS, taking into account evolution of the structural parameters in order to 
determine the phase maximum hydration, and implicitly coexistence of the bulk phase with excess water. 
The phase diagram shows a series of order to order transitions with the following phase sequence: Lα 
(green) Lα+Ia3d (green+orange) Ia3d (orange) Ia3d+Pn3m (orange+blue) Pn3m (blue) and at 
high temperature the transition Pn3m (blue) HII (violet). 
 
In the case of the most curved lipid in the series, DCPML, a most remarkable and unusual phase 
behavior was observed: the Ia3d cubic phase had already formed at 22℃ and at water content 
of 5% (w/w). Instead of the typical phase sequence upon hydration that was observed for most 
of the other MAGs, including the corresponding unsaturated lipid ML (La  Ia3d  Pn3m), 
hydrating the DCPML system resulted in an order-to-order phase transition from Ia3d to HII 
(Figure 7).  
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Figure 7.  Overlay of the binary phase diagrams of DCPML (solid lines) and ML (background) adapted 
from Kulkarni et al. (37). The sample composition/temperature phase diagram of the DCPML:water 
system was established by SAXS, taking into account evolution of the structural parameters in order to 
determine the phase formed at maximum hydration, and implicitly, the coexistence of the bulk phase 
with excess water. The phase diagram shows a series of order to order transitions with the following 
phase sequence: Ia3d (orange) Ia3d+ HII (orange+ violet)  HII (violet).  
 
The presence of a stable HII at physiological and room temperature is a remarkable finding 
compared to the other MAGs. Previous studies have shown that it is only possible to obtain 
stable HII phases with MAGs at room temperature by addition of hydrophobic molecules such 
as tetradecane or oleic acid (19, 24), or by having an ether bond instead the ester one linking 
the chain to the headgruop (38).  The HII phase has been successfully utilised in drug delivery 
(26, 39), and as a matrix for membrane protein reconstitution (40). The characteristic slower 
and prolonged release of hydrophilic molecule from HII renders this geometry particularly 
appealing for several applications. However, the difficulties related to the complexity of ternary 
systems have thus far limited the practicality of this mesophase. The stability of the HII phase 
at room temperature also suggested a shift of the phase behavior to lower temperatures and 
hydration. 
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In the case of MDS, it was hypothesized that absence of the HII phase was due to the different 
chain stretching energy of the cyclopropanated lipid in combination with the high packing 
frustration energy required for the formation of such a highly curved phase. Considering the 
new results, especially the unprecedented phase behavior of DCPML, in which the HII phase is 
stable in a large range of temperatures from 5°C to 105°C we can conclude that the rigidity of 
the cyclopropyl moiety doesn’t constitute a limit for the formation of a highly packed phase. 
We can also deduce that in analogy with the degree of unsaturation (37), increasing the number 
of cyclopropyl groups lowers the transition temperature between different phases. Moreover, 
Kulkarni et al. (37) compared the phase diagram of 4 different lipids: ME (1-monoelaidin), MV, 
MO, and ML in increasing order of chain splay. They demonstrated that increase in the chain 
splay of the lipidic molecule results in the stabilization of phases with an increasing negative 
curvature, and in the relative destabilization of the primitive bicontinuous cubic phase with a 
lower transition temperature to the more curved inverse micellar and inverse hexagonal phases. 
Interestingly, in the cyclopropanated systems the classic sequence MVMOML of 
increasing chain splay was inverted for the first two components. Considering the stability of 
the inverse hexagonal phase, with the transition to an inverse hexagonal phase at 85°C for the 
cyclopropanated analogous of MV (MLB), and assuming that this is stabilized by an increasing 
of chain splay we can propose a new chain splay sequence for the cyclopropanated lipids: 
MDSMLBDCPML. Because of the limited number of lipids that form LCPs and the 
complexity of the system it is hard to find general rules to predict the phase behavior and to 
design new morphologies able to form such phases.  
3.1.2 Low temperature phase behavior  
The hydrated MDS system forms a stable Pn3m cubic phase at 4°C (Figure 8). This observation 
is in accordance with the finding that the high-temperature boundaries of MDS phases are lower 
than those of MO. 
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Figure 8. 1D SAXS spectra of the scattered intensities versus scattering vector, q, depicting the 
diffraction patterns of MDS mesophases containing 50 % (w/w) water at the selected temperatures. The 
double diamond Pn3m cubic phase exists in the temperature range of 4-22 °C, as revealed by the SAXS 
diffraction peaks in the ratio: √2:√3:√4:√6:√8:√9. Reproduced with permission from (29). 
 
Currently available LCPs are often limited in the range of temperature over which they can be 
used, and are generally unstable at low temperatures (0–4 °C), undergoing phase transition into 
a lamellar crystalline phase (2, 6).  One of the most important applications of LCPs has been 
their potential in generating well-diffracting 3-D crystals of membrane proteins. To date, LCP-
generated crystals have yielded about 10 % of all membrane protein structures, but these 
crystals were obtained at room temperature. Although available LCPs, such as the widely used 
MO-based one, can form supercooled cubic systems that can be maintained to produce low-
temperature crystals under certain conditions (41), they do not form thermodynamically stable 
LCPs at low temperature, and are therefore prone to phase transition. In addition, the handling 
of minute amounts of LCP is not trivial, and any additional component, such as the various 
additives needed for membrane protein crystallization, may affect phase stability. The same 
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holds for surface effects, which are very pronounced when setting up small drops in the 
nanoliter range. 
Thus the instability of LCPs at low temperature greatly limits its use, and calls for the design 
and development of stable low-temperature LCPs for biochemical and biophysical studies. The 
reasons for seeking low-temperature LCPs are manifold: Some membrane proteins are 
notoriously unstable at room temperature (42), requiring low temperature for structural and 
functional studies. In addition, diffusion is known to be a necessary and crucial process in 
nucleation and crystal growth: too fast a diffusion may lead to irreversible aggregation and 
precipitation, while a too slow one may never lead to mature crystals. To have at one’s disposal 
LCPs in a very broad range of temperatures is a clear advantage for controlling diffusion in the 
lipidic bilayer and in the aqueous channels. Moreover, size of the aqueous channels of the LCPs 
is an important variable, and the larger the temperature range available, the more flexibility 
there is in terms of aqueous channel size. Lastly, recent advances in free electron laser (FEL) 
science and technology (43) offer novel prospects in structural biology. Specifically, the 
availability of LCP injectors makes is feasible to attempt to crystallize complexes of membrane 
proteins with other membrane proteins or with soluble proteins, which is at the frontier of 
membrane structural biology, requiring novel lipidic system that are thermodynamically stable 
at low temperature. 
To test the applicability of MDS low-temperature LCPs for the crystallization of membrane 
proteins, the light-induced proton pump bacteriorhodopsin (bR) was crystallized from MO- and 
MDS-LCPs at 20 °C in comparative experiments, as well as from MDS-LCP at 4 °C. Results 
of these experiments are presented in chapter 5. 
The peculiar low temperature behavior of MDS shows that the steric hindrance introduced with 
the kink of the cyclopropyl moiety may increase the ability of this family of lipids to maintain 
a more disordered liquid crystalline phase. This consideration was combined with the 
observation of a shift of the phase diagram of DCPML to lower temperatures and hydration, 
and the presence of the HII phase at room temperature. Therefore, the phase behavior of DCPML 
at low temperature was investigated, which resulted in the observation of an unusual stability 
of the curved bicontinuous cubic phase at lower than expected temperatures. SAXS 
measurements of the DCPML mesophase containing 30 % (w/w) water revealed a stable HII 
phase until 8℃. By lowering the temperature even further, the Ia3d cubic geometry was formed 
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and was retained until 0°C. From the measured lattice parameter of the Ia3d phase at 0 °C 
(127.58 Å) it was possible to calculate the radius of the aqueous channel (24.83 Å) as is reported 
in chapter 1 of this thesis. This complex phase behavior at low temperatures was further 
investigated using differential scanning calorimetry (DSC). 
In order to resolve first-order transition peaks corresponding to the phase transitions of bound 
and free water in the hydrophilic domains of the lyotropic liquid crystalline phases, DSC 
measurements of samples with various water contents were carried out. Since the melting 
temperatures of the bound and free water are typically different, this technique can provide 
insight into the thermodynamics of the liquid crystalline phase transitions. In pure water, by 
increasing the temperature from -70°C, a sharp peak for the first-order transition appears at 0°C. 
In DCPML LCPs, the water is confined in the mesophase channels and the size of the channels 
changes with composition of the sample, increasing its radius at higher hydrations. From DSC 
measurements on DCPML mesophases reported in Figure 9 it is possible to monitor how the 
peak for the freezing water changes according with the composition of the sample. Most 
importantly, the enthalpy peak is completely absent in the samples with 5 and 10% w/w of 
water. The sharp peak for the free water phase transition appears in the samples with 20% and 
25% w/w of water. Lowing the water content results in the peak changing its shape, suggesting 
a different nature of the water in the channel, until the complete absence of the peak for the 
bound water. At lower hydration the aqueous channels of the Ia3d phase become small enough 
to entirely confine the water. The DSC measurements also confirmed the phase transition 
temperatures that were measured by SAXS. A possible deviation of a few degrees in the 
transition temperatures can be explained by different heating rate and subsequent equilibration 
time, as well as an error (±0.5%) in the sample composition. 
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Figure 9. DSC traces of DCPML with water content ranging from 5 to 25% w/w. The peaks correspond 
to the first-order transitions of free and bound water in the samples with 25% w/w water (olive green), 
20% w/w water (magenta), 15% w/w water (blue). The first order transition peaks are absent for the 
samples with 10% w/w water (green) and 5% w/w water (red). Samples were heated from -70°C to 60°C 
with a scanning rate of 5 °C/min in a heat/cool/heat cycle. The traces presented in the figure were 
obtained during the second heating process. 
 
As a control experiment, samples of commercial Dimodan (monolinolein of 95% purity)  with 
various water contents were studied with DSC. The first order transition peak appears at 0°C 
for both compositions (Figure 10).  The lack of a first-order transition peak in the DSC suggests 
that the water in the channels of the Ia3d cubic phase in the low hydration regime, i.e. at 5% 
w/w and 10% w/w, is confined within the mesophase and therefore cannot freeze. It has been 
established that confinement of water in a range between 1 to 100 nm can prevent formation of 
the arrangement of water molecules in a tetrahedral ice structure, thereby preventing 
crystallization at any temperature, creating a state of supercooled water (44). 
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Figure 10. DSC traces of DCPML with 10% w/w water (red) and of Dimodan with 10% w/w water 
(blue) and 20% w/w water (olive green). The peaks correspond to the first-order transition of free and 
bound water in the Dimodan samples with 10% w/w water (pale blue) and 20% w/w water (green). 
Absence of the peak for the first order transition for the DCPML sample with 10% w/w water (red). 
Sample were heated from -70°C to 60°C with a scanning rate of 5 °C/min in a heat/cool/heat cycle. The 
curves presented in the figure are obtained during the second heating process.  
 
In order to calculate the radius of the LCPs’ aqueous channels, DCPML sample with 10% water 
was further investigated at low temperature by SAXS. The sample was cooled down to -7°C 
with a cooling rate of 0.5°C/min and kept at constant temperature for 36 hours. SAXS spectra 
were collected while increasing the temperature from -7 to 22 °C (Figure 11).  
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Temperature 
°C 
Lattice 
parameter Å 
Water channel 
radius Å  
22 94.19 7.08 
10 95.65 7.19 
0 96.50 7.24 
-7 98.80 7.34 
 
Figure 11. Lattice parameters and water channel radius of DCPML with 10% w/w water calculated 
from the SAXS spectra at various temperatures: 22 °C magenta, 10°C blue, 0°C red and -7°C black.  
 
Supercooling behavior of confined water has been studied in the last decade and was shown in 
systems such as carbon nanotubes (45) or porous silica hydrogels (46). It was also theoretically 
predicted that inverted micelles could induce supercooling (47), but this behavior has never 
been directly observed. It was already known that the dynamics of water in LCPs is dramatically 
altered relative to bulk water (48), affecting nearly all other kinetic phenomena, including 
small-molecule and ion transport (49). 
The discovery reported herein of a LCP system that is able to confine water and avoid its 
crystallization down to -70°C is directly related to the atypical phase behavior of DCPML. In 
fact, the presence of an Ia3d phase already at low water content is crucial for the formation of 
small aqueous channels able to confine the water in a cylindrical geometry. Moreover, the 
transition to a Lc phase of commercially available lipids at low temperature prevented the 
finding of supercooled bounded water in LCPs. 
3.2 Materials and methods  
Cyclopropanated lipids were synthetized according to the procedure previously reported by 
Salvati Manni et al. (29) and as reported in chapter 2 of this thesis. Purity of the lipids was 
confirmed by 1H-NMR, 13C-NMR and mass spectroscopy. 
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Mesophase sample preparation  
Liquid-crystalline mesophases were prepared by mixing weighed quantities of desired lipid and 
water (to achieve the desired composition of each sample of the phase diagram) inside sealed 
Pyrex glass tubes, followed by melting to a fluid isotropic state by gentle heating, mixing by 
vortex and centrifugation until a homogenous mixture was obtained. The prepared mesophases 
were then allowed to cool to room temperature over a period of 24 h in order for them to reach 
a state of thermodynamic equilibrium before SAXS measurements were performed. 
An alternative method using two 100 μL Hamilton syringes loaded with the weighed quantities 
of lipid and water, respectively was also employed.  After homogenization with the Hamilton 
coupled syringe setup, the obtained mesophases were transferred to 2mm quartz glass 
capillaries (Hilgenberg) between two layers of Teflon and sealed with a solvent free 2-
component epoxy resin adhesive (UHU plus). The sample was then melted to form an isotropic 
fluid, and subsequently equilibrated at room temperature for at least 24 h before measurements. 
Small-angle X-ray scattering (SAXS) measurements 
SAXS measurements were used to determine phase identity, identify the symmetry and unit 
cell parameters of the mesophases at the different conditions. Experiments were performed on 
a Rigaku SAXS instrument with MicroMax-002+ microfocused beam, operating at voltage 
and filament current of 45 kV and 0.88 mA, respectively. The Ni-filtered Cu Kα radiation 
(λCu Kα=1.5418 Å) was collimated by three pinhole (0.4, 0.3 and 0.8 mm) collimators and the 
data were collected with a two-dimensional argon-filled Triton detector. An effective 
scattering-vector range of 0.03 Å−1<q<0.45 Å−1 was probed, where q is the scattering wave 
vector defined as q=4π sin(θ)/λ Cu Kα, with a scattering angle of 2θ, calibrated using silver 
behenate. 2 mm quartz glass capillaries containing the sample were placed into a stainless 
steel holder. Additional measurements were performed on a Bruker AXS Micro, with a 
microfocused X-ray source, operating at voltage and filament current of 50 kV and 1,000 μA, 
respectively. The Cu Kα radiation (λCu Kα = 1.5418 Å) was collimated by a 2D Kratky 
collimator, and the data were collected by a 2D Pilatus 100K detector. 
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An effective scattering-vector range of 0.04 Å−1<q<0.5 Å−1 was probed. Samples were placed 
inside a stainless steel cell between two thin replaceable mica sheets and sealed by an O-ring, 
with a sample volume of 10 μL and a thickness of ∼1 mm. Measurements were performed at 
different temperatures, and samples were equilibrated for 30 minutes prior to measurements, 
while scattered intensity was collected over 30 minutes. For the low-temperature experiments 
special care was taken to exclude supercooling. 
Mesophases were identified by their specific Bragg peak positions. For the double diamond 
cubic phase (Pn3m) the relative positions in q of the Bragg reflections are at 
√2:√3:√4:√6:√8:√9…, whereas for the gyroid bicontinuous cubic phase (Ia3d)  the Bragg peaks 
are at q = √6:√8:√14:√16:√20…. The HII phase is identified by reflections at 1:√3:√4…, the 
bilayer lamellar (Lα) phase exhibits Bragg peaks in the ratio of 1:2:3:4… and the L2 phase is 
identified by a singular characteristic broad peak. The mean lattice parameter, a, was deduced 
from the corresponding set of observed interplanar distances, d (d = 2π/q), using the appropriate 
scattering law for the phase structure. For cubic phases:  
 (1) 
while for the HII phase:  
 (2) 
For the L2 phase, which shows only one broad peak, d is termed the characteristic distance.  
Differential scanning calorimetry (DSC) 
DSC experiments were performed on a Thermal Advantage DSC from TA Instruments. The 
samples were loaded in aluminium capsules contained in a steel sample pan of known mass and 
thermal conductivity. The experiments were carried out with an empty sample pan as the 
reference. Samples were allowed to equilibrate for at least 48h before the experiment, and were 
then scanned for a temperature range starting from −70 to 60 °C with a scanning rate of 5 
°C/min in a heat/cool/heat cycle. 
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Chapter 4 
 
Digestion of monoacylglycerols and their cyclopropanated 
derivatives: molecular structure and nanostructure determine 
rate of digestion. 
 
 
As fully hydrated mesophases (Pn3m, HII, etc.) can coexist with excess of water, they can be 
dispersed to form nanostructured particles in the presence of a surface stabilizer. They are 
named in accordance with the geometry of their internal nanostructure: dispersed cubic phases 
are called cubosomes (1)  and hexagonal phases are called hexosomes (2), analogous to 
dispersed lamellar particles, liposomes (3). Important physicochemical properties like 
thermotropicity, biodegradability and amphiphilicity of the bulk lipidic cubic phase (LCP) are 
correspondingly preserved in the dispersion (4), while retention of the geometry depends on the 
nature and the amount of the stabilizer (5). Such colloidal particles constitute a potential 
solution to the a number of issues associated with the size and complexity of the bulk systems 
and the difficulties in handling a viscous, sticky bulk mesophase (6). Because of their unique 
set of properties and their stability in aqueous environments, cubosomes have been largely 
studied as drug delivery systems for small hydrophilic (7) and hydrophobic (8) molecules. Since 
different geometries present different release rate upon dilution, on-demand manipulation of 
dispersed nanostructured particles that change their phase behavior has been developed as a 
method to control this release. For instance, dispersed cubic systems – cubosomes - exhibit 
burst release upon dilution, while liposomes and hexosomes are known to be slower releasing 
mesophases (4). The dynamic phase behavior alteration from a mesophase which is slow 
releasing to a mesophase that displays fast release with an external stimulus has been conceived 
as the trigger mechanism for the dynamic release of encapsulated drug (9). This has led recently 
to the development of stimuli responsive lipidic particles that respond to photothermal, 
magnetic, ultrasound stimuli as well as pH variation (4).  
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Upon ingestion, lipid metabolism and absorption takes place in the gastrointestinal tract which 
is regulated by enzymatic hydrolysis (10, 11). A first digestion takes place in the stomach with 
the action of the gastric lipase (12), followed by a second and more efficient digestion in the 
small intestine by water soluble pancreatic lipase at the oil-water interface (13).  This enzyme 
is responsible for the cleavage of the ester bonds that connect the glycerol head group to the 
lipidic chain(s). In the last few years, it has been shown that ester hydrolysis results in the 
complex dynamic transformation of the phase behavior of the digested lipid (14-16). These 
phase transitions from various lamellar and non-lamellar nanostructures, which were observed 
for the first time during digestion of olive oil (14) were recently characterized using synchrotron 
SAXS in animal (17) and human milk (18). This discovery has reinvigorated the search for 
synthetic and mixed lipid formulations, opening up the possibility of using enzymatic 
hydrolysis (19) as a stimulus to achieve the desired phase transitions in lipidic nanocarriers for 
a better assimilation of drugs, lipophilic vitamins and nutrients (20-24).   
Despite the fast development of basic research on cubosomes and the increasing popularity of 
these dispersed particles in last few years, few lipids have been engineered and tested for the 
development of new formulations. Additionally, few studies have systematically investigated 
absorption, metabolism and toxicity of these nanoparticles upon administration to the body, as 
this is one of the main limiting factors in the applicability of such materials. Interestingly, of 
the two most studied lipids that form LCP dispersions, phytantriol (PT) and MO, the former 
has shown higher toxicity in vitro, suggesting that monoacylglycerols are more biocompatible 
for drug delivery formulations (25). Since the phase behavior of the dispersed mesophases can 
be different from that of the original bulk phase, physicochemical characterization of new 
dispersed systems is essential for the development of novel smart stimuli-responsive materials.  
Cyclopropanated lipids have been found to be an important component of several bacterial 
membranes, different seed oils, plants and in a smaller amount within lipids produced by 
animals (26) and in mammalian tissues, including humans (27). Although cyclopropyl fatty 
acids are widely spread between different species and have been detected in several dairy 
products like milk and cheese (28), in nuts (29) and in wine (30), not much is known about the 
toxicity of these lipids to humans and the way they are processed and assimilated during 
digestion (27). Their interesting phase behavior in bulk makes them potential candidates for 
novel formulations. In this work, the dynamic digestion of three synthesized designer 
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cyclopropanated lipids that are able to form nanostructured colloidal particles have been 
studied, and their digestion is compared with that of the corresponding cis-unsaturated 
commercially available lipids. Time resolved SAXS measurements are used to monitor the 
phase changes during the digestion combined with kinetic data from the titration of the 
produced acid. 
4.1 Results and discussion 
The cyclopropanated lipids MDS (1-(cis-9,10-methylene-octadecanoyl)-rac-glycerol), CPMP 
(1-(cis-9,10-methylene-hexadecanoyl)-rac-glycerol) and DCPML (1-(cis-cis-9,10-12,13-bis-
methylene-octadecanoyl)-rac-glycerol), and their corresponding unsaturated lipids MO 
(monoolein), MP (monopalmitolein) and ML (monolinolein) were used to form dispersed 
nanostructured particles at 37 °C and their digestion behavior was studied with time-resolved 
synchrotron SAXS. Each lipid was dispersed (5% w/w) in a 0.5% Pluronic F108 in milliQ water 
and the initial phase was determined by SAXS, as shown in Figure 1, 2 and 3 as a red spectrum.  
The initial phases are different for the different lipids and the nanostructure was not always 
conserved in comparison with the bulk phase. For example, MP (Figure 2) forms a Pn3m phase 
in excess of water at 37°C, while in dispersion it forms a Im3m phase. In contrast, the 
corresponding cyclopropanated lipid CPMP (Figure 2) retains the Pn3m geometry upon 
dispersion, like in the bulk system. Studies on the phase retention of MO cubosomes show that 
the phase behavior can be strongly influenced by the stabilizer, and that Pluronic F108 is the 
most effective stabilizer in retaining the cubic geometry. In accordance with our data this phase 
retention is strongly dependent on the nature of the lipid, and stability tests have to be performed 
for the different formulations. Interestingly, MO and its corresponding cyclopropanated lipid, 
MDS (Figure 1), reveal a coexistence of Pn3m and Im3m phases with similar lattice parameters 
for the two different lipids, even though the two systems show different phase behaviors in bulk 
as is shown in the previous chapter of this thesis. Thus MO forms cubosomes of Pn3m and 
Im3m geometries with lattice parameters of 96 Å and 135 Å, respectively. Similarly, MDS 
forms Pn3m and Im3m dispersed particles with lattice parameters of 95 Å and 141 Å, 
respectively. As expected from the bulk phase diagram studies, pure ML forms a Pn3m phase, 
while the corresponding cyclopropanated lipid DCPML forms an HII phase at 37 °C as well as 
in bulk (Figure 3). This particular resistance of DCPML hexosomes to phase transition, 
together with the possibility to be still digested and eventually assimilated makes this novel 
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lipid extremely appealing for several applications that require a slow release phase which is 
stable at physiological temperature (31). 
 
Figure 1. SAXS profiles showing time-resolved intensity vs scattering vector q during the lipase 
digestion of a dispersion of MO (A) and MDS (C). SAXS spectra of the various phases that occur during 
the lipase-induced transformations are depicted for MO (B) and MDS (D). For both lipids the initial 
dispersion forms a coexistence of Im3m and Pn3m cubic phases, while subsequent digestion leads to the 
formation of pure Pn3m and eventually to the HII phase. The digestion of MO shows the final FI structure 
at 3500s, while MDS still presents a sharp HII signal at the same time. 
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Figure 2. SAXS profiles showing time-resolved intensity vs scattering vector q during the lipase 
digestion of a dispersion of MP (A) and CPMP (C). SAXS spectra of the various phases that occur 
during the lipase-induced transformations are depicted for MP (B) and CPMP (D). For MP the initial 
dispersion forms a Im3m phase, subsequent digestion leads to the formation of the Pn3m phase in 
coexistence with the initial Im3m. Further digestion leads to a coexistence of Im3m and HII phases and 
finally the system is digested to FI. For CPMP the initial dispersion forms a Pn3m phase, after 400s a 
complex phase coexistence with two different Im3m phases and a Pn3m has been characterized.  Further 
digestion leads to a coexistence of Im3m, Pn3m and HII phases, followed by two different HII phases and 
a final dissolution of the structure at ca. 2500s. 
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 Figure 3. SAXS profiles showing time-resolved intensity vs scattering vector q during the lipase 
digestion of a dispersion of ML (A) and DCPML (C). SAXS spectra of the various phases that occur 
during the lipase-induced transformations are depicted for ML (B) and DCPML (D). For ML the initial 
dispersion forms a Pn3m phase, subsequent digestion leads to the formation of the Im3m phase in 
coexistence with the initial Pn3m. Further digestion leads to HII phase and finally to FI. For DCPML 
the initial dispersion forms a HII phase, after 2500s the system evolves to a coexistence of two different 
HII phases that are stable for more than 3500s. 
 
Once digested, all the cubosomes are converted into hexosomes, but the transition between the two 
different cubic geometries (Pn3m-Im3m) can be inverted.  
The digestion of cyclopropanated lipids was found to be generally slower than that of the 
corresponding cis-unsaturated lipids. In the case of ML and DCPML the different rates could 
be rationalized by the different geometries and the slower diffusion of hydrophilic molecules 
in the HII phase than in a Pn3m cubic phase (32, 33), explaining the slower action of the enzyme 
that is confined in the aqueous channel. This approach cannot be considered for the MO-MDS 
systems that show similar initial phase behavior, but a different digestion rate. 
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This suggests that the packing arrangement of the lipidic chain influences the availability of the 
polar head group even if the geometry and the lattice parameters of the two phases are similar, 
resulting in a greater resistance to digestion for the cyclopropanated lipid.  
Time resolved NMR studies were performed in order to establish the relative amounts of sn1 
and sn2 hydrolysis during the digestion of MP. Figure 4 shows the 1H-NMR spectra at t=0 
when the only two lipid molecules in the mixture are 1-MP and 2-MP. After 1h digestion 
(Figure 5) the peaks of the digested lipids and the two esters are still present in the mixture. 
The ratio between 1-MP and 2-MP was calculated using the integral of the H2’ of both esters 
(the signal of H1’of 1-MP has the same chemical shift as that of the stabilizer), indicating that 
no significant change occurred. The total digestion was calculated using the ratio between the 
integral of the 1H of the olefin (H 9,10) and the signals from both esters: After 1h, 50% of both 
1-MP and 2-MP were hydrolyzed to acid. Kinetic experiments by acid titration were carried out 
to establish the rate of the reaction for the different lipids. After testing by NMR that both esters 
(sn1 and sn2) are hydrolyzed by the considered enzyme, with no remarkable selectivity for one 
of the two glycerol position, and considering that NMR kinetic measurements are less sensitive 
and did not show any substantial difference with the titration data, they were not performed on 
the synthetic lipids. 
 
 
Figure 4. 1H-NMR spectrum of the MP digestion mixture before lipase addition (t=0). The natural 
equilibrium of 1-MP and 2-MP is shown at the top of the figure. Signals related to 1-MP are reported in 
blue, signals related to 2-MP in red and the signal of the mixture in black. 
H 9, 10 H 2’ H 2’ 
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Figure 5. 1H-NMR spectrum of the MP digestion mixture at t=3600s after lipase addition. The natural 
equilibrium of 1-MP and 2-MP is shown at the top of the figure. Signals related to 1-MP are reported in 
blue, signals related to 2-MP in red and the signal of the mixture acid/ester in black. 
 
4.2 Materials and methods  
Cyclopropanated lipids were synthetized according to the procedure previously reported by 
Salvati Manni et al. (34) and as reported in chapter 2 of this thesis. Purity of the lipids was 
confirmed by 1H-NMR, 13C-NMR and mass spectroscopy. Monoolein (MO), Monopalmitolein 
(MP) and Monolinolein (ML) were purchased from Nu-Check. 4- bromophenylboronic acid (4-
BPBA, >95%) was purchased from Sigma Aldrich (St. Louis, MO, USA). Lipase USP grade 
pancreatin extract was purchased from Southern Biologicals (Nunawading, Victoria, Australia), 
the enzyme was reconstituted by dissolving 340mg of dry extract in 1.8 ml of digestion buffer 
(50 mM Tris maleate, 5 mM CaCl2·2H2O, 150 mM NaCl, 6 mM NaN3 as anti-microbial agent, 
pH adjusted with NaOH to 6.5) 
Preparation of nanostructured dispersions 
Nanostructured dispersions were produced by hydrating each lipid with 0.5% Pluronic F108 in 
milliQ water to prepare a 5% (w/w) lipid dispersion. The coarse dispersion was further 
processed with a probe sonicator with pulsed sonication for 10 min at 20% amplitude. Digestion 
buffer was added to obtain a 3% (w/w) lipid dispersion. 
are 
depicted 
H 9, 10 
H 2’ H 2’ 
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Small Angle X-ray Scattering (SAXS) 
Time resolved SAXS (TRSAXS) data for the enzymatic studies were collected on the 
SAXS/WAXS beamline at the Australian Synchrotron. In vitro digestion experiments were 
conducted in a thermostated glass digestion vessel at 37 °C (15). 10 mL of the dispersion was 
equilibrated in the digestion vessel before the remote addition of 1 mL of lipase solution (10 
mg/mL) to initiate digestion. The digestion medium was pumped (10 mL/min) through a 1.5 
mm quartz capillary flow cell using a peristaltic pump and the quartz capillary was placed in 
the X-ray beam (35).  
The scattering profiles were acquired for 5 s every 10 s at an energy of 10 keV using a Pilatus 
1 M detector (active area 169×179 mm2 with a pixel size of 172 μm) with a sample-to-detector 
distance of 1015 mm, providing a q range of 0.01 Å−1 < q < 0.7 Å−1. The scattering images were 
integrated into the one-dimensional scattering function I(q) using the in-house-developed 
software package ScatterBrain. The q range calibration was made using silver behenate as the 
standard. The cubic and hexagonal phase space groups and lattice parameters were determined 
by the relative positions of the Bragg peaks in the scattering curves, which correspond to the 
reflections on planes defined by their (hkl) Miller indices (36). 
Dispersed LLC phases in excess water are readily identified using SAXS, where each phase 
can be identified by its specific Bragg peak positions. For the double diamond cubic phase (V2, 
Pn3m) the Bragg reflections occur at relative position in q at √2:√3:√4:√6:√8:√9… and for the 
primitive bicontinuous cubic phase (V2, Im3m)  the Bragg peaks occur at q = √2:√ 
4:√6:√8:√10…. The HII phase is identified by reflections at 1:√3:√4…, and the L2 phase is 
identified by a singular characteristic broad peak. The mean lattice parameter, a, was deduced 
from the corresponding set of observed interplanar distance, d (d = 2π/q), using the appropriate 
scattering law for the phase structure. For cubic phases:  
 (1) 
while for the H2 phase:  
 (2) 
For the L2 phase, which shows only one broad peak, d is termed the characteristic distance. 
NMR studies  
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Nanostructured dispersions for NMR studies were prepared following the same procedure as 
described above. At t=0 a solution of pancreatin in digestion buffer was added to the lipidic 
dispersion. 2ml samples of the mixture were taken at different times and the enzymatic reaction 
was stopped by adding 200µl of the 4-BPBA solution (0.5M in MeOH). The dispersion was 
then freeze-dried to remove methanol, and the water phase was extracted with CH2Cl2. The 
organic layer was dried on NaSO4, filtered and evaporated. The lipid was then dissolved in 
CDCl3 and analyzed by 1H-NMR. 
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Chapter 5 
 
Membrane protein crystallization. 
 
 
In this thesis, four different membrane proteins have been studied with the purpose of 
investigating the utilization of lipidic cubic phases (LCPs) formed by tailor-made 
cyclopropanated lipids for membrane protein crystallization (exemplified by bacteriorhodopsin, 
bR) and for membrane protein structural studies (Escherichia coli chloride channel EcClC, 
Ralstonia metallidurans Rm1ClC, and the lipopolysaccharide transporter LptD-LptE). These 
membrane proteins will first be introduced, and subsequently their crystallization within LCPs 
and their diffraction resolution using synchrotron X-ray diffraction will be presented and 
discussed. 
 
Bacteriorhodopsin  
Bacteriorhodopsin (bR) is an integral membrane protein composed of the apoprotein 
bacterioopsin with its seven transmembrane α-helices, and the chromophore trans-retinal in the 
center of the structure connected through a Schiff base linkage to lysine 216 on helix G (1). bR 
is the best known light driven proton pump, it is powered by wavelengths of green light and it 
is the main component of the purple membrane (PM) of Halobacterium salinarum (2). The 
bacterial rhodopsin family is highly conserved among species especially in oceanographic 
bacteria, suggesting that rhodopsin mediated phototrophy is the most widespread mechanism 
to convert sunlight into chemical energy in biological systems (3). The structure of bR was the 
first structure of a membrane protein that was elucidated already in 1975: the presence of 2D 
crystals of bR clusters in the PM made it possible to get structural information via electron 
diffraction with a resolution of 7 Å (4). In the last four decades, bR has been extensively 
characterized and numerous structures have been deposited in the protein data bank: 84 by X-
ray diffraction, 6 by electron diffraction and 3 by NMR (1).  
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Most importantly for the purpose of this thesis, bR was also the first membrane protein that was 
crystallized, and whose high resolution X-ray structure elucidated using the LCP method (5). 
The crystal habit and diffraction limit of bR was shown to critically depend on the identity of 
the hosting LCP-lipid (5), albeit the molecular determinants of this dependency are still elusive. 
In a recent work (6) an atomic resolution movie of the conformational changes that occur in the 
nanoseconds to milliseconds after photoactivation of bR was elucidated using time resolved 
serial femtosecond crystallography at an x-ray free electron laser.  One of the 13 structural 
snapshots recorded is presented in Figure 1. 
 
Figure 1. Resting state structure at 2.0 Å resolution of bacteriorhodopsin. The 10 ligands reported in the 
structure are molecules of native lipids, lipidic metabolites and retinal. PDB 5B6V.  
 
Due its high stability and the ability to reproduce well known crystallization conditions, bR was 
chosen as a model membrane protein to test the applicability of cubic phases formed with 
cyclopropanated lipids for crystallization of membrane proteins, and to study the effect of a 
different lipidic environment on the protein crystal morphology. 
 
Lipopolysaccharide transporter 
The lipopolysaccharide transporter (Lpt) is a machinery which consists of 7 different proteins: 
LptA, LptB, LptC, LptD, LptE, LptF and LptG. This machinery spans the bacterial membrane 
and is responsible for the transport of lipopolysaccharides (LPS) from the cytoplasm to the cell 
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surface (7). LPS are complex glycolipids that form an integral component of the outer leaflet 
of the outer membrane (OM) of gram-negative bacteria. The presence of LPS on the OM is 
essential for the stability of the OM and for the survival of the bacteria in harsh conditions, and 
constitute one of the main factors in the development of bacterial resistance to antibiotics (8). 
The synthesis of LPS occurs on the surface between the inner membrane (IM) and the 
cytoplasm, and these amphiphilic molecules are then transported to the OM by Lpt (9). Recent 
research into antimicrobial peptides has unearthed a new family of antibiotics that presents a 
new mechanism of antibacterial action by targeting the outer membrane protein, LptD, in 
Pseudomonas aeruginosa (10). LptD is involved in the final step of the transport of the LPS 
from the IM to the OM; its main function being the insertion of the LPS into the outer leaflet 
of the OM (11). The ability of the peptidomimetic antibiotics to bind LptD results in the 
inhibition of the transport of LPS to the cell surface, and therefore an increase in the 
permeability of the OM and consequently a decrease in bacterial viability (12). 
The most studied peptidomimetic antibiotic active on LptD is L27-11, a cyclic peptide that 
contains a 12-residue loop folded in an β-hairpin conformation (Figure 2). 
 
 
Figure 2.  β-hairpin structure of the cyclic peptide L27-11 obtained by NMR. Dotted arrows indicate 
long range NOEs. Reproduced with permission from (12). 
 
 L27-11 shows antimicrobial activity against many Pseudomonas strains in nanomolar 
concentration, while it is almost completely inactive against other gram-negative bacteria (12). 
Although the LptD sequence and structure has been shown to be highly conserved for different 
gram-negative bacteria, LptD in Pseudomonas strains has an N-terminal domain that is 90 
amino acids longer than LptD in E. coli and S. flexneri. The C-terminal domain of LptD creates 
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a transmembrane β-barrel pore composed of 26 antiparallel β-strands that is linked to the N-
terminal domain by two pairs of non-consecutive disulfide bonds. An interesting feature of the 
periplasmic N-terminal domain is the β-jellyroll which consists of two β-sheets with eleven 
antiparallel β-strands each (8, 13, 14). 
 
Figure 3. Crystal structure at 2.39 Å resolution of LptD/E from S. flexneri. PDB 4Q35. 
 
In order to determine the mechanism of action of the transporter and the role of the different 
Lpt proteins, they are being studied separately. In particular, in this thesis, we have attempted 
to crystallize LptD from P. aeruginosa in the absence and in the presence of the peptidomimetic 
antibiotic L27-11 in order to understand the structure and the inhibition mechanism of this 
protein. These crystallization experiments were carried out in LCPs. 
LptD is purified in a complex together with the lipoprotein LptE. The structure of LptE is 
essential in forming a stable LptD-LptE complex, where the lipoprotein is attached to the N-
terminus of LptD and resides within the LptD β-barrel. Its location is necessary for the correct 
folding of LptD, and at the same time, the LptE lipidic tail is embedded in the OM anchoring 
the machinery into the lipidic bilayer (11). LptE has also an essential role in the selective 
binding of LPS, and in the prevention of the passage of various compounds across the LptD β-
barrel pore. Recently, high resolution crystal structures of the LptD-LptE complex from S. 
typhimurium and S. flexneri have been solved (Figure 3) (13, 14). However, the mechanism of 
action of L27-11 is still unresolved. The crystal structure of the complex LptD-LptE from 
75 
 
 
Pseudomonas aeruginosa could provide important information on the special conformation of 
the N-terminal domain of this protein and on the specific mechanism of action of the antibiotic.  
 
Chloride channel and transporters 
Chloride channels and transporters (ClCs) are membrane proteins abundant in eukaryotic and 
prokaryotic organisms. ClCs are atypical membrane proteins as they are made up of a dimer 
with distinct molecular architecture that catalyzes chloride movement across membranes in two 
distinct mechanisms: chloride-selective passive channels and secondary active chloride/proton 
antiporters. Since their first discovery in 1979 (15), ClCs have been identified in all kingdoms 
of life, including nine ClC homologues in humans (16-20). These nine ClC proteins can be 
found in the plasma membrane as gated chloride channels and play four essential roles: the 
maintenance of the membrane potential, epithelial ion transport, chloride-proton antiporters in 
membranes of intracellular vesicles of the endosomal-lysosomal pathway, and regulation of 
vesicular acidification. They play a diverse role in a variety of physiological processes and their 
malfunction can lead to several diseases such as myotonia congenita, osteoporosis, and Bartter’s 
syndrome (21). However, several of their functions are not yet known and thus a better 
understanding of their behavior on a molecular level is necessary.  
The structural determination of two bacterial homologs (Salmonella typhimurium StClC and 
Escherichia coli EcClC) (Figure 4) (22, 23), combined with results of functional studies, shed 
light for the first time on the mechanism of the chloride-proton antiporters and revealed that the 
chloride movement is coupled to proton translocation with a 2:1 stoichiometry (24).  
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Figure 4. Crystal structure at 3.5 Å resolution of EcClC and Fab Complex.  PDB 1KPK.  
 
Currently, it is believed that approximately half of the ClC family consists of transporters and 
it is debated how the dualism channel-transporter appeared during the course of evolution (25). 
The structure of EcClC represented a breakthrough in our understanding of this protein family, 
and subsequently the crucial characterization of the architecture of the well-conserved 
transmembrane transport domain was achieved. This membrane protein is a homodimer with 
two identical subunits, each consisting of 18 α-helices and an independent ion translocation 
pore. The two subunits are organized in an antiparallel architecture. In contrast to eukaryotic 
ClCs, which are equipped with cytoplasmic domains, EcClC consists only of the catalytic 
transmembrane domain. 
The cytoplasmic domain, when present, is well conserved amongst the ClC family and it was 
shown to be important for the regulation of function. The high resolution structure is available 
for several ClC homologues and each constitutes of a tandem repeat of two CBS (cystathionine 
β synthase) subdomains. The ClC homologue from Ralstonia metallidurans (RmClC) is one of 
the few prokaryotic ClCs that contain cytoplasmic domains. The cytoplasmic domain of RmClC 
was crystallized and the structure solved and described in the dissertation of Dr. Sandra 
Markovic (University of Zurich, 2010), however, the transmembrane domain structure is still 
unknown. Crystallization of the full length protein and of the transmembrane domain segment 
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was attempted during this PhD thesis. In addition, the family of ClC channels and transporters 
is of great importance in physiology and medicine, and structural information of full length 
homologues containing a cytoplasmic domain are not yet available. Because EcClC crystals 
were previously obtained from detergent solution but not from LCPs, an LCP-based 
methodology towards their crystallization was developed.  
 
5.1 Results and discussion 
5.1.1 Bacteriorhodopsin 
To test the applicability of the cyclopropanated analogous of monoolein, MDS (1-(cis-9,10-
methylene-octadecanoyl)-rac-glycerol) for the crystallization of membrane proteins in low and 
room temperature LCPs, the light-induced proton pump bacteriorhodopsin (bR) was 
crystallized from MO- and MDS-LCPs at 20 °C in comparative experiments, as well as from 
MDS-LCP at 4 °C.  
 
 
Figure 5. Comparison of bR crystals grown in MDS at 4 °C (A) and 20 °C (B). BR crystals in MDS 
constitute the first reported crystals of an integral membrane protein (IMP) grown at 4 °C from LCP. 
(C) Quality of σA-weighted 2mFo-DFc electron density map of bR crystallized in MDS at 20 °C, 
contoured at 1.5 σ. Reproduced with permission from (26) 
 
Plate-like hexagonal crystals with an average size of ∼18 x 18 x 7 µm were observed after 3 
days in MDS at 20 °C, and grew to the full size (∼40 x 40 x 20 µm) in 10 days (Figure 5b). In 
contrast, crystallization in monoolein (MO) was slower, yielding fewer initial crystals (sized 
∼20 x 20 x 7 µm) under identical conditions after 10 days. These crystals grew to the full size 
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in 28 days but remained smaller (∼30 x 30 x 12 µm) than in the MDS case. Moreover, using 
the same crystallization screen, crystals appeared in a much broader range of conditions in MDS 
than in MO. The best crystals observed at 4 °C were obtained from MDS after 28 days (Figure 
5a). Crystals were subjected to X-ray crystallographic analyses using synchrotron radiation. 
They belonged to space group P63, with one protein molecule in the asymmetric unit. The best 
diffraction was obtained from crystals grown from MDS-LCP at 20 °C, and the structure was 
refined at 1.83 Å resolution (Figures 6 and 7).  
 
Figure 6. Crystal structure of bR in MDS at 20 °C, shown as a physiological trimer. Left: view 
perpendicular to the plane of the membrane from the cytoplasmic side. Right: view along the plane of 
the membrane depicting the extracellular (EC) and cytoplasmic (CP) sides. Reproduced with permission 
from (26). 
 
The packing arrangement of unit cells was found to be lamellar as expected for protein crystals 
grown in LCP. (Figure 7) 
 
Figure 7. Crystal packing of bR crystallized from MDS LCP at 20 °C. Unit cell axes are indicated. 
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Reproduced with permission from (26) 
 
The quality of σA-weighted 2mFo-DFc electron density map is shown in Figure 5C. bR crystals 
grown from MDS LCP at 4 °C were very small (∼15 x 15 x 5 µm), yet the crystal structure 
could be solved at 4.2 Å resolution (Figure 8), with identical unit cell parameters as those of 
the structure generated 20 °C, confirming the validity of the approach at low temperature.  
 
Figure 8. σA-weighted 2mFo-DFc electron density map of bR crystallized from MDS LCP at 4 °C, 
contoured at 1.5 σ. Left: view perpendicular to the plane of the membrane from the cytoplasmic side. 
Right: view along the plane of the membrane depicting the extracellular (EC) and cytoplasmic (CP) 
sides. Reproduced with permission from (26). 
 
Interestingly, the c axis in the MDS-grown crystals is unusually short (100 Å vs. 110 +/- 2 Å in 
the MO-grown crystals). This may be due to the smaller thickness of the lipid bilayer formed 
by the geometrically confined and kinked MDS, resulting in shorter c axis in the crystal, which 
is parallel to the transmembrane helices.  
Crystals grown from MDS-LCP at 20 °C 
Crystals belonged to space group P63, with one protein molecule in the asymmetric unit. X-ray 
diffraction data were collected from several crystals cryo-cooled to 100 K at beamline X06DA 
(Swiss Light Source, Villigen, Switzerland) with the PILATUS 2M high-resolution 
diffractometer at a wavelength λ = 1 Å. Data were processed and scaled with XDS (27). 
Resolution of the data crossed I/σ(I) = 2.0 at ~2.1 Å and the data were finally cut at 1.83 Å with 
CC1/2= 10.2% (28). As previously reported (29, 30) , the crystals exhibited merohedral twinning 
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with a twin fraction of 30% - 40%. 
The structure was determined by molecular replacement in Phaser (31) using the highest-
resolution bR structure (Protein Data Bank accession code 1M0L, 1.47 Å, crystals grown in the 
LCP) as a search model. The search model was prepared by removing all non-protein atoms 
except the retinal. Model building was done in Coot (32) and refinement was performed with 
REFMAC5 (33) and Phenix (34). The final R/Rfree of the model is 0.1824 / 0.2120, with 
Ramachandran favored 99% and Ramachandran outliers 0%. Data collection and refinement 
statistics are shown in Table 1 and were generated with Phenix Graphical Tools (35).  
Crystals grown from MDS-LCP at 4 °C 
Crystals belonged to space group P63, with one protein molecule in the asymmetric unit and 
with identical unit cell parameters to those of the crystals grown from MDS-LCP at 20 °C. X-
ray diffraction data were collected from a single crystal cryo-cooled to 100 K at beamline 
X06SA (Swiss Light Source, Villigen, Switzerland) with the PILATUS 6M high-resolution 
diffractometer at a wavelength λ = 1 Å. Data were processed and scaled with XDS (27). 
Resolution of the data crossed I/σ(I) = 2.0 at ~7.1 Å and the data were finally cut at 4.2 Å with 
CC1/2 = 66.7% (28) and with completeness = 92.5% in the highest resolution shell. 
The structure was determined by 5 cycles of rigid-body refinement in REFMAC5 (33) with the 
high-resolution 20 °C-generated bR structure as a starting model, and due to the relatively low 
resolution of the data was not refined further. Data collection and merging statistics are shown 
in Table 1.  
 
  bR 20 °C bR 4 °C 
Wavelength (Å) 1 1 
Resolution range (Å) 46.69 - 1.83 (1.895 - 1.83) 36.36 - 4.04 (4.318 - 4.174) 
Space group P63 P63 
Unit cell (Å) 60.94 60.94 100.13  61.05 61.05 100.15 
90° 90° 120°  90° 90° 120° 
Total reflections 238704 (24408) 7304 (722) 
Unique reflections 18616 (1862) 1296 (144) 
Multiplicity 12.8 (13.1) 4.9 (5.0) 
Completeness (%) 99.99 (100.00) 80.80 (92.31) 
Mean I/sigma(I) 9.22 (0.59) 1.06 (0.98) 
R-merge 0.2502 (4.378) 1.068 (1.697) 
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R-meas. 0.2607 1.198 
CC1/2 0.998 (0.102) 0.909 (0.667) 
CC* 0.999 (0.372) 0.976 (0.786) 
R-work 0.1824 N/A 
R-free 0.212 N/A 
Number of non-hydrogen atoms 1988 N/A 
 macromolecules 1760 N/A 
 ligands 217 N/A 
 water 11 N/A 
Protein residues 226 N/A 
RMS(bonds) (Å) 0.002 N/A 
RMS(angles) (°) 1.1 N/A 
Ramachandran favored (%) 99 N/A 
Ramachandran outliers (%) 0 N/A 
Clashscore 6.03 N/A 
Average B-factor 48.1 N/A 
 macromolecules 45.4 N/A 
 ligands 69.4 N/A 
 solvent 51.9  N/A 
Table 1. Data collection and refinement statistics. Statistics for the highest-resolution shell are shown 
in parentheses. 
 
 
5.1.2 Lipopolysaccharide transport machinery 
Crystals of LptD/E-His6 were obtained in the presence of Zn(OAc)2 0.01 M, MES buffer 
100mM, pH 6.0 and PEG 200 40%. Tetragonal bipyramidal microcrystals were observed after 
4 days in MO at 20 °C, and grew to the full size (∼20 x 10 µm) in 15 days (Figure 9). Resolution 
of the data crossed I/σ(I) = 2.0 at ~6Å which was not high enough to proceed further in structure 
elucidation. However, it provides a very interesting starting point for fine-tuning for optimal 
crystallization conditions.  
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Figure 9. LptD/E-His6 crystals grown at 20 °C for 15 days in MO-LCP. These crystals diffract to a 
resolution of 6 Å. 
 
In order to optimize the crystal growth special screening of precipitant conditions was designed, 
varying systematically the pH (from 5.5 to 6.5), salt concentration (from 0.01 to 0.05 M of 
Zn(OAc)2) and the nature and the concentration of the PEG (PEG 200 and 400 from 35 to 45%). 
The concentration of the protein was also varied and plates were set up with protein 
concentration of 10 mg/ml and 15 mg/ml. Crystallization plates were incubated at 20 °C for 30 
days but no protein crystals were observed. 
The same screening was made with a protein solution (10 mg/ml) that was previously mixed 
with the synthetic peptide L27-11. The LCP were formed directly with the solution peptide-
protein. The concentration of the peptide was calculated in order to have 2 equivalents of 
peptide (calculated on a volume of 850 nl) for each equivalent of protein (calculated in 50 nl). 
Crystals were observed (Figure 10) in several conditions and X-ray diffraction data were 
collected but none of them resulted in protein crystals. 
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Figure 10.  Crystals of a small molecule (most probably L27-11) grown in MO at 20°C in presence of 
L27-11 in the protein solution.  
 
Despite being unsuccessful in the optimization of crystal growth and determination of the 
structure of the target protein, it was shown that the LCP method is suitable for the 
crystallization and structural analysis of a large, transmembrane complex of proteins. It is 
noteworthy that the published structure of a LptD-LptE complex was obtained from crystals 
grown from a detergent solution (13, 14). 
5.1.3 Escherichia coli chloride channels EcClC 
EcClC was crystallized in LCPs in order to find similarities and differences with crystals 
previously obtained from vapor diffusion experiments (22). LCP boli were set up screening 
different conditions and different protein concentrations. Crystals were obtained in the 
following conditions: KCl 0.5 M, PEG 400 35%, sodium acetate 0.05M, pH 4.5, protein 
concentrations: 15 and 25 mg/ml; potassium sodium tartrate 0.1 M, PEG 400 35%, ADA 0.05 
M, pH 4.5, protein concentration: 15 mg/ml; ammonium sulfate 0.2 M, PEG 400 45%, TRIS 
0.05 M, pH 8.4, protein concentration: 25 mg/ml.  
X-ray diffraction data were collected, but only crystals grown in ammonium sulfate 0.2 M, PEG 
400 45%, TRIS 0.05 M, pH 8.4 showed a protein diffraction pattern. Data were processed and 
scaled with XDS (27). Resolution of the data crossed I/σ(I) = 2.0 at ~9Å. 
Crystallization experiments were set up in the conditions defined above, screening protein 
concentration from 15 to 25 mg/ml. Protein crystals were obtained with a protein concentration 
of 22 mg/ml (Figure 11). They grew to full size of 50 x 40 x 10 µm and diffracted to a resolution 
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of ~6 Å.  
 
Figure 11. EcClC crystals grown in MO-LCP at 20 °C diffracting to 6 Å. A) image observed with 
normal light, B) corresponding image recorded between cross polarizers and C) with UV-fluorescence 
microscopy.  
 
In order to optimize crystal growth of the protein after His-tag cleavage, special screening 
protocol of precipitant conditions was designed by systematically varying the pH (from 7.5 to 
9.5), ammonium sulfate concentration (from 0.1 to 0.2 M) and the concentration of the PEG 
(PEG 400 from 33% to 57%). Crystallization experiments were set up at protein concentration 
of 22 mg/ml and using two different LCPs: MDS and MP (Figure 12).  
 
Figure 12. EcClC crystals grown in LCPs of A) MDS,  diffracting up to 7 Å and B) MP, diffracting up 
to 4 Å at 20 °C. Image observed with normal light  
 
X-ray diffraction data were collected on crystals from various setups. The crystals grown from 
MO-LCP at 20 °C with protein concentration 22 mg/ml in the presence of ammonium sulfate 
0.2 M, PEG 400 40%, TRIS 0.05 M, pH 8.4 (Figure 13) showed the best diffraction. 
A B C 
B A 
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Figure 13. EcClC crystals grown in MO-LCP at 20 °C and diffracting to 3.4 Å. A) Image observed with 
normal light, B) corresponding image recorded between cross polarizers.  
 
The structure of EcClC was solved by molecular replacement and refined up to 3.4 Å.   (Figure 
14-16). 
 
Figure 14. Crystal structure of EcClC in MO at 20 °C, shown as a dimer. 
 
Packing arrangement of the proteins was found to be lamellar, as expected for membrane 
protein grown in LCP. (Figure 15) 
A B 
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Figure 15. Crystal packing of EcClC crystallized from MO-LCP at 20 °C. Unit cell axes are indicated. 
 
In the structure solved for the LCP-grown EcClC, the protein exhibits an identical conformation to that 
in the structure obtained from vapor diffusion crystals, which was used as a model for the molecular 
replacement (22).   
 
Figure 16. σA-weighted 2mFo-DFc electron density map of EcClC dimer crystallized from MO-LCP at 
20 °C, contoured at 1 σ. 
 
Interesting details emerge from the analysis of the difference electron density map (FO-FC ). 
From the map it was possible to build additional residues in the N and C termini that were not 
resolved in the structure obtained from the vapor diffiusion crystallization (22).   
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5.1.4 Ralstonia metallidurans chloride channels Rm1ClC 
Crystallization screens of the full length Rm1ClC and of its transmembrane domain alone were 
set up in parallel, with protein concentrations of 15, 20, and 25 mg/ml in MO-LCP. While the 
full length protein did not crystallize, crystals of Rm1ClC TM were obtained in the presence of 
0.2 M (NH4)2SO4, 0.05 M NaOAc, 4.5 pH buffer, PEG 400 35%. Rod-like microcrystals were 
observed after 9 days in MO-LCP at 20 °C, grew to the full size (∼7 x 2 x 2 µm) in 20 days 
(Figure 17), and diffracted to low resolution. These crystallization conditions were used as a 
starting point for fine-tuning in search for optimal crystallization conditions.  
 
 
Figure 17. Rm1ClC crystals grown at 20 °C for 20 days in MO-LCP, diffracting to a resolution of 12 
Å. 
 
In order to optimize the crystal growth, special screening protocol of precipitant conditions was 
set up, varying systematically the pH (from 4 to 5), NaOAc concentration (from 0.01 to 0.1 M) 
and the PEG concentration (PEG 400 from 30 to 40%). The concentration of the protein was 
kept at 22 mg/ml. Crystallization plates were set up with LCP formed from MO and MP and 
were incubated at 20 °C. Crystals appeared in MO-LCPs in several conditions after 7 days, and 
grew to full size (∼15 x 2 x 2 µm) in 20 days (Figure 18).  Resolution of the data crossed I/σ(I) 
= 2.0 at ~6Å, which was not high enough to proceed further in structure determination. 
However, it provides a very interesting starting point for fine-tuning en route to optimal 
crystallization conditions. Interestingly, no crystals were obtained from MP-LCPs. 
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Figure 18. Rm1ClC crystals grown at 20 °C for 20 days in MO-LCP. Diffracting resolution was 6 Å. 
A) image observed with normal light, B) the corresponding image recorded between cross polarizers 
 
Further crystal optimization was attempted by changing lipid for the formation of LCPs. 
Monooelaidin (ME) and a mixture of MO with 10% cholesterol were mixed with the protein 
solution to form the LCPs. After 7 days at 20 °C microcrystals appeared in both LCP set ups, 
but only the crystals in the MO-cholesterol mixture grew further after 20 days to size of ∼7 x 2 
x 2 µm, and diffracted up to ~7Å resolution.  
Despite being unsuccessful in the optimization of crystal growth and determination of the high-
resolution structure of the target protein, it was shown that the LCP method is suitable for the 
crystallization and structural analysis of chloride channels, and that changing lipid can be an 
essential step in crystal growth and optimization.  
 
EcClC Crystals grown from MO LCP at 20 °C 
Crystals belonged to space group C2221, with one protein molecule in the asymmetric unit. X-
ray diffraction data were collected from several crystals cryo-cooled to 100 K at beamline 
X06DA (Swiss Light Source, Villigen, Switzerland) with the PILATUS 6M high-resolution 
diffractometer at a wavelength λ = 1 Å. Data were processed and scaled with XDS (27). 
Resolution of the data crossed I/σ(I) = 1.8 at 3.4 Å and the data were finally cut at 3.4 Å with 
CC1/2= 71.2% (28). 
The structure was determined by molecular replacement in Phaser (31) using the EcClC 
structure (Protein Data Bank accession code 1OTS, 2.5 Å, crystals grown in vapor diffusion) 
as a search model. Model building was done in Coot (32) and refinement was performed with 
Phenix (34). The R/Rfree of the model is 0.2469 / 0.2770, with Ramachandran favored 95%.  
A B 
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5.2 Materials and methods 
Cyclopropanated lipids were synthetized according to the procedure previously reported by 
Salvati Manni et al. (26) and as reported in chapter 2 of this thesis. Purity of the lipids was 
confirmed by 1H-NMR, 13C-NMR and mass spectroscopy. 
Monoolein (MO), Monopalmitolein (MP) and Monooelaidin (ME) were purchased from Nu-
Check. 
5.2.1 Bacteriorhodopsin 
Purification of bR from purple membranes 
Lyophilized Halobacterium salinarum purple membranes (PM) were purchased from Sigma-
Aldrich (product No. B0184). Bacteriorhodopsin (bR) was purified from PM according to an 
established procedure (36). 
Briefly, 2 mg of lyophilized PM were resuspended in 2 ml of an aqueous solution of 150 mM 
KCl and collected by centrifugation (30 min, 20,000 g, 4 °C). The pellet was resuspended in 6 
ml of 25 mM sodium phosphate buffer, pH 6.9. Subsequently, 2 ml of an aqueous 10% (w/v) 
n-octyl-β-D-glucopyranoside (OG, Anatrace) were added, the sample was sonicated for 1 min 
and incubated overnight in the dark. Prior to ultra-centrifugation (45 min, 120,000 g, 4 °C), the 
pH was adjusted to 5.5 with 0.1 N HCl. The supernatant was concentrated to 500 µl with an 
Amicon ultra centrifugal concentrator (30 kDa cutoff, Millipore) and subjected to size-
exclusion chromatography on a Superdex 200 Increase 10/300GL column (GE Healthcare) pre-
equilibrated with a 25 mM sodium phosphate buffer, pH 5.5, 1.2% OG at 4 °C. Pooled peak 
fractions were concentrated with an Amicon ultra centrifugal concentrator (30 kDa cutoff) to 
10.2 mg/ml as judged by the absorption peak at 560 nm. The final absorbance ratio A280/A560 
was 1.51. 
Data collection and structure determination 
Crystals were grown from MO and MDS LCPs as described previously (5), and appeared as 
thin hexagonal plates. The crystals were mounted on the Dual-Thickness MicroMounts 
(MiTeGen) directly from the lipidic mesophase and were flash-frozen in liquid nitrogen.  
Lipidic cubic phase crystallization of bR 
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Detergent-solubilized bR was reconstituted into the LCP by mixing with molten MO or MDS 
in a 2:3 (v/v) ratio (protein solution:lipid) using a syringe lipid mixer as previously described 
(37). Following formation of a transparent, uniformly colored purple LCP, 50-70 nl LCP boli 
were dispensed onto 96-well plastic plates (Swissci) and overlaid with 800 nl precipitant 
solution using the Gryphon LCP robot (Art Robbins Instruments). A specific screening protocol 
of precipitant conditions was made, varying systematically the pH (from 5.2 to 7.7) and Na/K-
Pi concentration (from 1.5 to 3 M). Crystallization plates were incubated either at 20 °C (MO, 
MDS) or at 4 °C (MDS). 
Plate-like hexagonal crystals with an average size of ∼18 x 18 x 7 µm were observed after 3 
days in MDS at 20 °C, and grew to the full size (∼40 x 40 x 20 µm) in 10 days. In 
contradistinction, crystallization in MO was slower, yielding fewer initial crystals (∼20 x 20 x 
7 µm) under identical conditions (2.1 M Na/K-Pi, pH 5.3) after 10 days. These crystals grew to 
the full size in 28 days but were smaller (∼30 x 30 x 12 µm). Moreover, using the same 
crystallization screen, crystals appeared in many more conditions in MDS than in MO. The best 
crystals (∼15 x 15 x 5 µm) obtained at 4 °C could be observed in MDS after 28 days using the 
following conditions: saturated Na/K-Pi, pH 6.9. 
A Zeiss Axioskop 2 MOT optical microscope and a Nikon Eclipse TE300 inverted microscope 
were used for observations with brightfield and cross polarized light. Images were captured by 
a Hamamatsu C5810 CCD camera. 
 
5.2.2 LptD-LptE 
Lipidic cubic phase crystallization of the LptD-LptE complex 
The purified LptD-LptE complex was obtained from Dr. Gloria Andolina from the group of 
Prof. John A. Robinson, Department of Chemistry, University of Zurich. Expression and 
purification of the LPtD-LptE complex was part of Dr. Andolina’s PhD thesis (2016), and 
crystallization trials were set up together as a collaborative project. The detergent-solubilized 
heterodimeric protein complex of LptD and LptE-His6 from P. Aeruginosa was reconstituted 
into the LCP by mixing a protein solution with protein concentration of 10 mg/ml (20 mM 
NaH2PO4, 500 mM NaCl, pH 7.4, 0.015% LDAO and 10% glycerol) with molten MO in a 2:3 
(v/v) ratio (protein solution:lipid) using a syringe lipid mixer as previously described (37). 
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Following formation of a uniformly transparent LCP, 50 nl LCP boli were dispensed onto 96-
well plastic plates (Swissci) and overlaid with 800 nl precipitant solution using the Gryphon 
LCP robot (Art Robbins Instruments). Six commercially available screens were set up to probe 
different crystallization conditions, whereby four were based on the conditions reported in the 
literature for the crystallization from detergent solution of the analogue LptD-LptE complex 
from E.coli (13, 14). 
The pH was fixed at 8.5 using a TRIS/HCl buffer system, the PEG 1000 and PEG 400 
concentration was varied from 15% to 5%. The precipitation salt was changed from NaBr to 
KBr, and both the systems were tried at two different concentrations (500mM and 200mM). 
Crystals were obtained for the commercial screening MenMeso (Molecular Dimensions) in the 
presence of Zn(OAc)2 0.01 M, MES buffer 100mM, pH 6.0 and PEG 200 40%. A Zeiss 
Axioskop 2 MOT optical microscope and a Nikon Eclipse TE300 inverted microscope were 
used for observations with brightfield and cross polarized light. Images were captured by a 
Hamamatsu C5810 CCD camera. 
The crystals were mounted on the Dual-Thickness MicroMounts (MiTeGen) directly from the 
lipidic mesophase and were flash-frozen in liquid nitrogen.  
Synchrotron X-ray diffraction data were collected from several crystals cryo-cooled to 100 K 
at beamline X06DA (Swiss Light Source, Villigen, Switzerland) with the PILATUS 2M high-
resolution diffractometer at a wavelength λ = 1Å. Data were processed and scaled with XDS 
(27). Resolution of the data crossed I/σ(I) = 2.0 at ~6Å . 
5.2.3 Chloride channels and transporters  
EcClC Expression  
The purification and expression of EcClC was described in the dissertation of Dr. Adrian 
Szydelko in the group of Prof. Raimund Dutzler, Department of Biochemistry, University of 
Zurich (2014). All EcClC expression plasmids used in this work were provided by Prof. 
Raimund Dutzler. For crystallization trials EcClC plasmids were freshly transformed into the 
BL21(DE3) E. coli strain. The bacteria were grown in a Luria Broth (LB) medium containing 
50 µg/ml of kanamycin in baffled flasks, shaking at 90 RPM. The temperature was maintained 
at 37 °C until cell growth reached OD600 of 1.0, then the cultures were cooled to 20 °C and 0.2 
mM isopropyl β-D-thiogalactopyranoside (IPTG) was added to the medium to induce the 
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expression. The expression was carried out for 14 h at 20 °C. The typical large-scale expression 
culture of EcClC was carried out in 32 l of total culture volume. The cultures were harvested 
by centrifugation for 15 min at 5000 RPM (Sorvall SLC-6000 rotor), and the pellets were used 
immediately. 
 
Membrane preparation and purification of EcClC  
A buffer with 50 mM Tris-HCl at pH 7.4 and 150 mM sodium chloride, 20 µg/ml DNase, 1 
mg/ml lysozyme, 1 µg/ml leupeptin, 1 µg/ml pepstatin was used to resuspend the pellets. The 
solution was homogenized and then run 3 times at >10000 psi in an EmulsiFlex-C3 (Avestin) 
pressure homogenizer to mechanically lyse the cells. After addition of 1 mM PMSF inhibitor, 
the solution was centrifuged for 45 min at 10 000 g, the supernatant collected and centrifuged 
for 90 min at 45 000 RPM (Ti70 rotor, Beckman Coulter). Using a Potter homogenizer, the 
resultant pelleted were resuspended in a buffer composed of 100 mM sodium chloride and 50 
mM HEPES at pH 7.4. Membrane vesicles suspension was frozen in liquid nitrogen and 
subsequently stored at -80 °C.  
EcClC was purified at room temperature. The frozen membranes were extracted with 50 mM 
n-decyl-β-D-maltoside (DM) SOL-grade (Affymetrix) for 2 h at room temperature. The extract 
was centrifuged for 40 min at 45,000 RPM (Ti70 rotor, Beckman Coulter) and the supernatant 
loaded onto a TALON affinity resin (Clontech) for immobilized metal affinity chromatography 
(IMAC). The column was washed with 40 mM imidazole and the desired protein eluted with 
400 mM imidazole. LysC endoproteinase (Roche) 0.3 U per 5 mg of protein was added to the 
eluted protein and incubated for 1.5 h to cleave the His-tag. The protein was concentrated to 
15±20 mg ml-1 with the Amicon MWCO 30 kDa centrifugal filtration unit (Millipore) and then 
run on a Superedex 200 10/300 GL column (GE Healthcare) in 45 mM DM, 150 mM NaCl and 
10 mM TrisHCl at pH 7.5. The fractions corresponding to the monodisperse elution peak at 
12.3 ml were collected and the protein concentrated using an Amicon MWCO 30 kDa 
centrifugal filtration unit. A280 was measured and protein concentration was calculated 
considering 1 mg/ml=1.0 AU. 
Lipidic cubic phase crystallization of EcClC 
Detergent-solubilized EcClC was reconstituted into the LCP by mixing a protein solution with 
concentration of 15 and 25 mg/ml with molten MO in a 2:3 (v/v) ratio (protein solution:lipid) 
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using a syringe lipid mixer as previously described (37). Following formation of a uniformly 
transparent LCP, 50 nl LCP boli were dispensed onto 96-well plastic plates (Swissci) and 
overlaid with 800 nl precipitant solution using the Gryphon LCP robot (Art Robbins 
Instruments). 20 commercially available screens were set up to probe different crystallization 
conditions. 
A Rock Imager 1000, Formulatrix key features was used for observation and imaging with 
brightfield, cross polarized and UV light.  
The crystals were mounted on the Dual-Thickness MicroMounts (MiTeGen) directly from the 
lipidic mesophase and were flash-frozen in liquid nitrogen.  
Synchrotron X-ray diffraction data were collected from several crystals cryo-cooled to 100 K 
at beamline X06DA (Swiss Light Source, Villigen, Switzerland) with the PILATUS 6M high-
resolution diffractometer at a wavelength λ = 1 Å. 
RmClC Expression 
The purification and expression of RmClC was described in the dissertation of Dr. Sandra 
Markovic in the group of Prof. Raimund Dutzler, Department of Biochemistry, University of 
Zurich (2010). All RmClC expression plasmids used in this work were provided by Prof. 
Raimund Dutzler. For RmClC crystallization trials the expression plasmids were freshly 
transformed into the MC1061 E. coli strain. The bacteria were grown in a Terrific Broth (TB) 
medium containing 50 µg/ml ampicillin in baffled flasks, shaking at 90 RPM. The temperature 
was maintained at 37 °C until cell growth reached OD600 of 0.6, the cultures were then cooled 
to 25 °C and 0.001 % (w/v) arabinose (Sigma-Aldrich) was added to the medium to induce the 
expression. The expression was carried out for 15 h at 25 °C. The typical large-scale expression 
culture of full length (FL) protein RmClC FL and its transmembrane (TM) domain was carried 
out in 32 l of total culture volume. The cultures were harvested by centrifugation for 15 min at 
5000 RPM (Sorvall SLC-6000 rotor) and the pellets were used immediately.  
Membrane preparation and purification of Rm1ClC FL and its TM domain. 
A buffer with 50 mM Tris-HCl at pH 7.4 and 150 mM sodium chloride, 20 µg/ml DNase, 1 
mg/ml lysozyme, 1 µg/ml leupeptin, 1 µg/ml pepstatin was used to resuspend the pellets. The 
solution was homogenized and then run 3 times at >10000 psi in an EmulsiFlex-C3 (Avestin) 
pressure homogenizer to mechanically lyse the cells. After addition of 1 mM PMSF inhibitor, 
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the solution was centrifuged for 45 min at 10 000 g, the supernatant collected and centrifuged 
for 90 min at 45 000 RPM (Ti70 rotor, Beckman Coulter). Using a Potter homogenizer, the 
resultant pellets were resuspended in a buffer composed of 150 mM sodium chloride, 50 mM 
Tris-HCl at pH 7.4 and 5% (v/v) glycerol. Suspension of membrane vesicles were frozen in 
liquid nitrogen and stored at -80 °C.  
RmClC FL and TM were purified at 4 °C. The frozen membranes were extracted with 50 mM 
n-decyl-β-D-maltoside (DM) SOL-grade (Affymetrix) for 1.5 h. The extract was centrifuged 
for 40 min at 45,000 RPM (Ti70 rotor, Beckman Coulter) and the supernatant loaded onto a 
TALON affinity resin (Clontech) for immobilized metal affinity chromatography (IMAC). The 
column was washed with 20 mM imidazole and the desired protein eluted with 300 mM 
imidazole. In order to cleave the His-tag and remove imidazole HRV 3C protease (GE 
Healthcare) was added at a 1:10 (w/w) ratio to the eluted protein and incubated for 2 h in a 8000 
MWCO dialysis membrane (Spectrum Laboratories), dialyzing against 40 volumes of the 
purification buffer supplemented with 2.5 mM DM SOL-grade. After cleavage the deca-His tag 
and green fluorescent protein (GFP) encoded with RmClC TM were removed from the protein 
sample with a second IMAC. This step was not required for the RmClC FL because its 
expression construct did not encode GFP molecule. 2 ml of NiNTA resin (Qiagen) was 
incubated with the protein solution for 15 min to bind the impurities, the flow-through fraction 
was collected and concentrated to 15±20 mg ml-1 with the Amicon MWCO 50 kDa centrifugal 
filtration unit (Millipore), and then run on a Superedex 200 10/300 GL column (GE Healthcare) 
in 150 mM sodium chloride, 10 mM Tris-HCl pH 7.4, 5 mM DM and 5 % (v/v) glycerol. The 
fractions corresponding to the monodisperse elution peak at 12.2 ml for the FL and 12.6 for the 
TM were collected and the protein concentrated using an Amicon MWCO 50 kDa centrifugal 
filtration unit. A280 was measured and protein concentration was calculated considering 1 
mg/ml=1.0 AU for RmClC FL and 0.595 AU for RmClC TM. 
 
Lipidic cubic phase crystallization of Rm1ClC 
Detergent-solubilized Rm1ClC was reconstituted into the LCP by mixing a protein solution 
with concentration of protein of 22 mg/ml with molten MO in a 2:3 (v/v) ratio (protein 
solution:lipid) using a syringe lipid mixer as previously described (37). Following formation of 
a uniformly transparent LCP, 50 nl LCP boli were dispensed onto 96-well plastic plates 
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(Swissci) and overlaid with 800 nl precipitant solution using the Gryphon LCP robot (Art 
Robbins Instruments). Best diffracting crystals of Rm1ClC TM were grown in MO at 20 °C for 
21 days. The LCP boli were incubated with an overlay of a precipitant solution with 0.2 M 
(NH4)2SO4, 0.02 M NaOAc pH 5 buffer , PEG 400 30 %.     
A Rock Imager 1000, Formulatrix key features was used for observation and imaging with 
brightfield, cross polarized and UV light.  
The crystals were mounted on the Dual-Thickness MicroMounts (MiTeGen) directly from the 
lipidic mesophase and were flash-frozen in liquid nitrogen.  
X-ray diffraction data were collected from several crystals cryo-cooled to 100 K at beamline 
X06DA (Swiss Light Source, Villigen, Switzerland) with the EIGER 16M X high-resolution 
diffractometer at a wavelength λ = 1 Å. 
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Conclusions  
 
 
In this thesis, novel lipids that demonstrate a complex polymorphism for the formation of 
alternative lipidic mesophases were successfully designed, synthesized, characterized and 
applied. These molecules were engineered and synthesized by replacing the central structural 
element of the commonly used monoacylglycerols (MAGs)- the cis double bond along the 
hydrophobic chain- with a cyclopropyl group. This project focused on four different 
commercially available MAGs, MO, MP, MV and ML. Repacement of the cis double bonds 
with cyclopropyl moieties resulted in the following designer lipids: MDS, CPMP, MLB, 
DCPML respectively. The molecules were systematically varied by altering the number of the 
cyclopropyl groups, the position of the cyclopropanation, and the chain length, in order to create 
a new family of lipids with similar properties. Various synthetic routes were explored in order 
to optimize the yields, which allowed for the production of grams of material necessary for the 
characterization and the application of the novel lipids. 
The binary phase diagrams of these systems were studied by mixing lipid and water at precise 
compositions, and SAXS measurements at different temperatures were recorded in order to 
establish the phase identity and geometry, as well as the lattice parameters as a function of 
temperature and water content. The phase boundaries were defined and the resultant phase 
diagrams were built in accordance with the data. 
Of particular interest were the low temperature behavior of the two systems MDS and DCPML. 
MDS exhibits a stable Pn3m bicontinuous cubic phase at 4 ℃ opening up the intriguing 
possibility of applying for the first time LCP crystallization of thermally unstable membrane 
proteins at low temperature. 
In the case of DCPML, the unusual chain splay played a determinant role in the phase 
transitions, obtaining an uncommon and unique phase behavior at both room and low 
temperature. This system reveals a stable HII phase at room temperature at high level of 
hydration (30%), and an Ia3d cubic phase already at 5% of water content. Most remarkably, 
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the low water content (5-10%) Ia3d cubic phase confined the incorporated water molecules in 
the bicontinuous aqueous channels, preventing water reorganization into a crystalline structure 
even at temperatures down to -30 ℃. DSC measurements combined with self-diffusion NMR 
experiments were carried out in order to determine the nature of the water in the channel. The 
absence of an enthalpy peak in the DSC around 0℃ confirmed the lack of a first order transition, 
which corresponds to the freezing of water. Preliminary NMR studies show the diffusion of 
water until -30 ℃ leading to the conclusion that the water confined in the channel retains its 
liquid characteristics even at low temperature. 
In order to test the capacity of these systems to switch phase on demand, and establish their 
applicability as drug carriers, enzymatic digestion of MDS, CPMP and DCPML dispersions 
were investigated. Phase changes during digestion were characterized with dynamic SAXS and 
the digestion behavior compared to that of the commercially available natural MAGs MO, MP 
and ML. Differences in phase formations and in digestion time were taken under considerations. 
Crystallization of the model system bR was attempted in LCPs made up of all the four 
cyclopropanated lipids in order to test their applicability as membrane protein crystallization 
matrixes. To show the applicability of MDS for membrane protein crystallization at low 
temperatures, bR was successfully crystallized at room temperature and at 4 ℃. 
To determine protein structure in native-like environments, three additional membrane proteins 
were investigated: The two chloride channels EcClC and Rm1ClC, and the lipopolysaccharide 
transporter LptD-E. For all the proteins studied, it was possible to obtain low resolution 
diffracting crystals (6 Å) in LCPs. Whereas for Rm1ClC and LptD-E it was not possible to 
obtain better diffracting crystals, optimization of the LCP crystal growth led to successful 
determination of the structure of EcClC. 
In conclusion, in this work four new designer cyclopropanated lipids were synthesized, their 
phase behavior was characterized and possible applications of the ensuing nanomaterials as 
drug delivery systems and membrane protein crystallization matrices were explored. 
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Abbreviations 
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4-BPBA 4- bromophenylboronic acid 
bR bacteriorhodopsin 
br broad 
CBS cystathionine β synthase 
ClC chloride channel 
CP cytoplasmic 
CPMP cyclopropyl monopalmitolein 
CPP critical packing parameter 
CPP  propionic acid 
d doublet 
DADS  4,4’-diaminostilbene2,2’-disulfonic acid 
DCPML dicyclopropyl monolinolein 
DIDS  4,4’-diisothiocyanostilbene2,2’-disulfonic acid 
DMAP 4-(dimethylamino)pyridine 
DMF dimethylformamide 
DSC differential scanning calorimetry 
EC extracellular 
EcClC Escherichia coli chloride channel 
EDC N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
ESI electrospray ionization 
FFT  fast Fourier transform 
FI isotropic fluid 
FL full lenght 
GPCR G protein-coupled receptors 
H hexagonal 
HI normal hexagonal 
HII inverse hexagonal 
HRMS high resolution mass spectroscopy 
Ia3d gyroid 
IM inner membrane 
Im3m primitive 
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IPTG isopropyl β-D-thiogalactopyranoside 
L micellar 
L1 normal micellar 
L2 inverse micellar 
LB Luria Broth 
Lc solid crystalline amellar 
LCP lipidic cubic phases 
LLC lyotropic liquid crystal 
LPS lipopolysaccharides 
Lpt  lipopolysaccharide transporter 
Lα liquid crystalline lamellar  
m multiplet 
MAG monoacylglycerols 
MDS monodihydrosterculin 
ME monoelaidin 
ML monolinolein 
MLB monolactobacillin 
MO monoolein  
MP monopalmitolein 
MV monovaccein 
NMR nuclear magnetic resonance 
NPPB  5-nitro-2-(3-phenylpropylamino)benzoic acid 
OADS  4,4’-octanamidostilbene2,2’-disufnate 
OG n-octyl-β-D-glucopyranoside 
OM outer membrane 
ompF  outer membrane protein F 
PDB protein data bank 
PM purple membrane 
Pn3m double diamond 
Q cubic 
q quadruplet 
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quint quintet 
Rm1ClC Ralstonia metallidurans chloride channel 
s singlet 
SAXS small angle x-ray scattering 
StClC Salmonella typhimurium chloride channel 
t triplet 
TB Terrific Broth 
TEM transmission electron microscopy 
TLC thin-layer chromatography 
TM transmembrane domain 
TPMS  triply-periodic minimal surface 
XFEL  X-ray free electron laser 
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NMR characterization 
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Spectrum 1. 1H NMR (500 MHz, CDCl3) of 1-MDS and 2-MDS (6-8%) mixture 
 
  
Spectrum 2 . 13C NMR (125 MHz, CDCl3) of 1-MDS and 2-MDS (6-8%) mixture  
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Spectrum 3. 1H NMR (500 MHz, CDCl3) of CP-palmitoleic acid 
 
 
Spectrum 4. 13C NMR (125 MHz, CDCl3) of CP-palmitoleic acid  
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Spectrum 5. 1H NMR (500 MHz, CDCl3) of 1-CPMP and 2-CPMP (10%) mixture 
 
 
Spectrum 6. 13C NMR (125 MHz, CDCl3) of 1-CPMP and 2-CPMP (10%) mixture  
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Spectrum 7. 1H NMR (500 MHz, CDCl3) of lactobacillic acid 
 
 
Spectrum 8. 13C NMR (125 MHz, CDCl3) of lactobacillic acid 
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Spectrum 9. 1H NMR (500 MHz, CDCl3) of 1-MLB and 2-MLB (6-7%) 
 
 
Spectrum 10. 13C NMR (125 MHz, CDCl3) of 1-MLB and 2-MLB (6-7%) 
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Spectrum 11. 1H NMR (500 MHz, CDCl3) of DCP-linoleic acid 
 
 
Spectrum 12. 13C NMR (125 MHz, CDCl3) of DCP-linoleic acid 
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Spectrum 13. 1H NMR (500 MHz, CDCl3) of 1-DCPML and 2-DCPML (7-8%) mixture 
 
 
Spectrum 14. 13C NMR (125 MHz, CDCl3) of 1-DCPML and 2-DCPML (7-8%) mixture 
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Spectrum 15. 1H NMR (500 MHz, CDCl3) of OADS 
 
 
Spectrum 16. 13C NMR (125 MHz, CDCl3) of OADS  
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Spectrum 17. 1H NMR (500 MHz, CD3CN) of 4,4'-oleamidostilbene-2,2'-disulfonate 
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Appendix 3 
 
 
Lattice parameters analysis 
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Figure 1. (a) Temperature dependence of the lattice parameters for the different phases (triangle=Lα, 
square=Ia3d, circle=Pn3m) observed in the MDS:water system at the indicated sample compositions (% 
(w/w) water). (b) Composition dependence of the different MDS:water mesophase lattice parameters at 
the indicated temperatures.  
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Figure 2. Temperature dependence of the lattice parameters for the different phases (triangle=Lα, 
square=Ia3d, circle=Pn3m) observed in the MLB:water system at the indicated sample compositions (% 
(w/w) water). 
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